rfhg_218398.1

Basic information about the TSS

---

TSS ID: rfhg_218398.1 Species: human Chr: chr20		Start: 17659606 End: 17659645 Strand: -
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000610403.4:-328 GeneID: 6238 HGNC/MGI_ID: HGNC:10448 UniProt_ID: A0A087WVV2 Nearer transcript ids and distances: AL833822:333 AF007575:-334 view more...

Gene_name: ribosome binding protein 1 Gene_symbol: RRBP1 Gene_synonyms: ES/130 hES p180 Gene_source: HGNC:10448

TATA-Box annotation

---

Distance to TSS:	22617
Nearest PromoterID:	NM_001365613
Entrez ID:	6238
Nearest Unigene:	Hs.472213
Nearest Refseq:	NM_004587
Nearest Ensembl:	ENSG00000125844
Gene Name:	ribosome binding protein 1
Gene Alias:	ES/130|ES130|RRp|hES
Gene Type:	protein-coding
CpG%:	0.025641
GC%:	0.600000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@RRBP1 p2@RRBP1 p3@RRBP1 p4@RRBP1 p5@RRBP1 p6@RRBP1 p7@RRBP1 p8@RRBP1
Sample		p1@RRBP1	p2@RRBP1	p3@RRBP1	p4@RRBP1	p5@RRBP1	p6@RRBP1	p7@RRBP1	p8@RRBP1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	44.80	15.78	0.19	0.00	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	39.05	13.15	0.20	0.20	0.20	0.00	0.00	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	42.82	13.89	0.00	0.00	0.39	0.00	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	41.79	8.73	0.21	0.21	0.21	0.21	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	44.99	14.17	0.45	0.00	0.00	0.22	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	41.28	11.63	0.19	0.19	0.00	0.00	0.19	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	47.06	16.12	0.00	0.65	0.00	0.22	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	37.54	14.05	0.24	0.24	0.00	0.24	0.24	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	36.97	13.46	0.00	0.00	0.00	0.21	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	47.53	11.01	0.58	1.16	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	51.74	17.38	0.40	0.40	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	42.69	12.60	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	20.15	6.77	0.16	0.16	0.00	0.16	0.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	22.25	8.72	0.00	0.30	0.00	0.00	0.45	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	19.54	10.10	0.88	0.22	0.22	0.00	0.00	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	23.14	6.79	0.25	0.00	0.00	0.00	0.00	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	20.53	8.95	0.44	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	24.89	9.70	0.42	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	25.06	11.20	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	17.15	8.58	0.30	0.00	0.00	0.15	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	24.19	7.22	0.27	0.00	0.13	0.00	0.13	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	23.13	7.42	0.17	0.17	0.00	0.00	0.17	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	18.61	7.37	0.78	0.00	0.13	0.13	0.00	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	21.11	9.46	0.00	0.00	0.24	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	25.54	10.06	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	22.47	6.96	0.95	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	25.82	5.49	0.55	0.00	0.00	0.00	0.55	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	27.58	13.67	0.71	0.00	0.00	0.24	0.47	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	22.77	10.18	0.48	0.65	0.16	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	23.53	9.77	0.36	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	22.61	7.54	0.63	0.00	0.21	0.00	0.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	17.78	5.67	0.59	0.00	0.00	0.00	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	20.89	8.44	0.21	0.00	0.00	0.00	0.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	27.22	9.57	0.16	0.00	0.16	0.00	0.00	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	23.19	7.48	0.37	0.00	0.00	0.00	0.00	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	21.27	7.86	0.00	0.00	0.19	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	20.64	6.74	0.00	0.20	0.00	0.00	0.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	19.75	7.25	0.60	0.00	0.40	0.00	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	23.50	9.99	0.81	0.00	0.00	0.27	0.00	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	24.49	6.24	0.96	0.24	0.00	0.00	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	18.35	7.06	0.24	0.00	0.00	0.00	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	24.16	7.17	0.44	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	20.25	6.54	0.21	0.00	0.00	0.00	0.00	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	23.25	9.09	0.35	0.00	0.17	0.00	0.00	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	22.29	11.85	0.20	0.00	0.00	0.20	0.00	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	24.20	10.00	0.47	0.23	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	23.99	5.52	0.24	0.24	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	23.84	6.56	0.30	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	28.96	14.36	0.24	0.24	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	30.53	8.29	0.20	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	27.05	8.40	0.82	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	35.80	14.45	0.67	0.22	0.22	0.22	0.00	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	125.93	13.99	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	30.52	12.42	0.35	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	38.77	18.23	1.33	0.00	0.33	0.00	0.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	79.70	12.58	8.39	1.68	0.00	0.00	1.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	39.95	12.86	1.38	0.46	0.46	0.00	0.46	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	40.84	19.12	0.65	0.00	0.00	0.32	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	33.72	15.09	1.28	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	43.06	15.40	1.26	0.63	0.63	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	32.43	19.74	0.71	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	35.89	16.26	0.56	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	42.20	15.13	1.59	3.18	0.00	0.00	0.00	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	36.36	16.31	1.02	0.34	0.34	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	31.52	13.32	1.95	0.32	0.00	0.00	0.65	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	40.47	20.59	0.71	0.35	0.35	0.00	0.71	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	177.80	64.66	32.33	16.16	0.00	0.00	0.00	16.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	213.23	55.28	23.69	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	50.21	29.25	0.49	0.00	0.00	0.49	0.00	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	64.96	30.25	2.98	0.99	0.00	0.00	0.00	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	57.70	30.96	0.47	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	59.61	31.46	2.65	0.00	0.66	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	43.00	33.10	0.62	0.62	0.31	0.62	0.00	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	48.31	25.99	1.83	0.31	0.00	0.00	0.00	0.00
Adipocyte - breast, donor1	11376-118A8	95.51	36.75	0.63	0.00	0.16	0.00	0.16	0.32
Adipocyte - breast, donor2	11327-117E4	78.61	35.29	2.41	1.93	2.41	0.80	1.60	0.64
Adipocyte - omental, donor1	11473-119C6	148.47	53.56	1.15	0.25	0.64	0.25	0.38	0.00
Adipocyte - omental, donor2	11474-119C7	46.34	21.68	0.00	0.00	1.49	0.00	0.75	0.00
Adipocyte - omental, donor3	11475-119C8	48.56	23.78	0.00	0.33	0.00	0.00	0.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	53.59	21.69	0.00	2.55	0.64	1.28	0.64	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	45.08	16.49	0.00	1.10	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	56.45	23.48	0.00	0.00	0.45	0.00	0.45	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	44.83	15.99	0.00	0.70	0.17	0.00	0.00	0.35
Adipocyte differentiation, day04, donor1	13019-139D4	151.96	50.46	0.78	0.20	0.20	0.39	0.20	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	149.79	51.22	0.26	1.03	0.00	0.00	0.26	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	115.97	39.03	0.28	0.56	0.28	0.00	0.28	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	98.16	31.74	0.00	0.00	0.00	0.00	0.00	1.18
Adipocyte differentiation, day08, donor1	13020-139D5	94.27	26.70	0.32	0.24	0.16	0.32	0.16	0.00
Adipocyte differentiation, day08, donor2	13023-139D8	81.98	30.98	0.00	0.32	0.65	0.65	0.32	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	76.25	20.79	2.13	1.60	0.53	0.00	0.00	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	84.02	30.60	0.00	0.56	0.00	0.00	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	76.94	23.29	0.00	0.42	0.00	0.42	0.42	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	78.11	22.60	0.00	0.75	0.50	0.50	0.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	61.85	17.34	0.00	0.65	0.65	0.33	0.33	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	71.25	25.58	0.30	0.30	0.61	0.00	0.00	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	127.29	33.59	0.22	0.22	0.22	0.00	0.22	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	64.54	23.31	0.36	1.43	0.72	0.72	0.00	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	46.72	23.96	0.00	0.00	2.40	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	129.35	44.80	0.54	0.36	0.72	0.36	0.18	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	83.67	30.12	0.00	1.67	0.00	1.67	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	115.46	48.49	0.41	0.62	0.62	0.21	0.21	0.41
Anulus Pulposus Cell, donor1	11248-116E6	188.57	50.12	0.46	0.80	1.03	1.03	0.34	0.46
Anulus Pulposus Cell, donor2	11463-119B5	83.27	36.98	0.24	0.73	0.49	0.49	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	69.64	17.97	1.80	1.80	0.45	0.45	0.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	82.92	25.18	0.43	3.91	0.43	0.43	0.43	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	55.65	23.54	0.00	2.14	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	65.46	24.51	0.60	0.90	0.90	1.20	0.30	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	74.61	25.29	1.26	2.53	3.79	2.53	0.00	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	46.20	23.76	1.32	2.64	0.00	0.00	1.32	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	65.95	20.47	0.65	1.62	0.97	0.00	0.00	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	74.27	24.76	0.00	1.46	1.46	1.46	0.97	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	65.92	21.38	0.59	0.59	1.19	0.00	0.59	1.19
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	70.81	29.00	0.38	1.88	1.51	0.75	0.38	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	75.47	23.22	1.45	1.45	1.45	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	48.90	6.27	0.00	1.25	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	91.10	25.37	0.16	0.16	0.49	0.16	0.16	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	83.25	30.03	4.09	0.00	0.00	1.36	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	59.26	20.96	0.00	0.75	0.15	0.15	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	73.94	28.40	0.54	0.54	2.14	0.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	61.97	24.94	0.94	0.76	0.38	0.19	0.57	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	81.25	30.74	0.80	1.34	0.80	0.80	0.00	0.80
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	74.13	18.53	0.98	0.98	0.98	2.93	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	56.39	24.22	0.33	0.50	1.00	0.66	0.33	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	45.63	22.81	1.20	3.60	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	84.96	14.16	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	70.67	27.96	0.69	0.86	0.86	1.89	0.34	0.51
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	33.56	25.17	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	71.36	23.79	0.97	0.00	0.00	3.40	0.49	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	78.93	28.84	1.90	1.14	1.14	0.38	0.00	1.14
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	81.16	20.59	0.00	2.42	1.21	0.00	0.00	2.42
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	62.13	21.09	0.57	0.57	0.57	0.57	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	60.93	22.66	0.21	1.71	1.07	0.43	0.43	0.86
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	71.49	30.45	0.77	1.03	0.26	0.52	0.26	0.52
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	72.73	24.40	0.47	1.41	0.94	1.41	0.47	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	67.85	28.94	1.29	0.96	0.64	0.32	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	57.08	21.40	1.43	1.43	0.71	0.71	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	59.67	19.30	1.17	1.17	0.58	0.00	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	56.60	23.48	1.51	0.00	0.30	0.60	0.00	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	52.27	20.20	1.19	0.00	3.56	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	72.72	25.43	2.03	2.03	0.51	0.00	0.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	66.98	25.98	0.25	2.04	2.29	1.27	0.25	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	53.37	22.87	0.00	0.00	0.64	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	68.18	23.73	0.00	1.29	1.29	0.43	0.43	1.29
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	56.73	22.23	0.21	1.48	0.64	0.42	0.42	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	49.30	17.69	1.16	1.16	0.58	0.29	0.00	1.16
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	84.08	24.56	0.00	0.94	0.94	1.89	0.00	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	52.38	22.72	0.85	0.85	0.51	0.51	0.00	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	53.28	30.11	0.00	0.00	0.00	0.00	0.00	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	126.75	12.68	0.00	2.11	4.23	0.00	0.00	2.11
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	66.25	19.73	0.43	1.50	1.07	1.50	0.43	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	60.77	22.86	1.20	0.00	0.00	0.60	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	70.71	15.31	1.46	0.00	0.00	0.00	0.73	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	59.77	22.30	0.23	0.69	0.46	0.92	0.23	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	94.36	15.30	0.00	7.65	5.10	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	61.27	21.10	0.00	0.25	0.00	0.00	0.00	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	70.40	27.46	0.41	1.65	1.24	1.45	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	67.32	26.62	0.31	1.84	0.31	0.00	0.61	0.61
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	78.39	22.47	1.43	1.91	0.00	0.48	0.96	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	64.75	25.06	0.44	0.89	1.11	0.22	0.00	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	59.51	21.36	1.53	0.00	3.05	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	68.13	25.48	0.00	0.55	0.00	1.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	69.11	28.60	0.79	1.06	0.53	0.53	0.26	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	63.97	23.99	1.09	1.09	0.00	0.00	0.36	0.73
Astrocyte - cerebellum, donor1	11500-119F6	188.65	39.42	0.49	0.49	0.12	0.25	0.00	0.12
Astrocyte - cerebellum, donor2	11580-120F5	146.68	53.06	1.03	1.37	0.51	1.20	0.34	0.17
Astrocyte - cerebellum, donor3	11661-122F5	110.12	24.75	1.47	0.21	0.21	0.63	0.42	0.63
Astrocyte - cerebral cortex, donor1	11235-116D2	58.91	14.64	0.00	0.35	0.00	0.00	0.00	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	56.78	12.62	0.65	1.78	0.49	0.49	0.00	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	61.60	24.46	0.60	1.34	0.45	0.75	0.30	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	48.05	13.76	1.03	0.69	1.26	0.46	0.23	0.23
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	43.10	14.16	0.13	0.63	0.63	0.88	0.13	0.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	51.89	13.66	0.34	0.46	0.80	0.46	0.23	0.23
Basophils, donor1	12241-129G9	35.31	7.85	0.00	0.00	0.00	0.00	0.26	0.00
Basophils, donor2	12242-129H1	69.63	21.65	0.36	0.36	0.00	0.00	0.00	0.00
Basophils, donor3	12243-129H2	54.83	20.58	0.88	0.15	0.00	0.00	0.00	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	58.00	12.94	0.22	0.22	0.00	0.22	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	32.92	10.06	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	43.04	28.69	0.00	7.17	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	23.85	10.04	1.26	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	44.50	17.68	1.25	0.21	0.00	0.21	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	30.86	9.90	0.69	0.00	0.00	0.00	0.23	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	44.81	19.97	0.18	0.90	1.08	0.72	0.72	0.54
Burkitt's lymphoma cell line:DAUDI	10422-106C8	138.51	35.24	0.62	0.10	0.62	0.10	0.62	0.10
Burkitt's lymphoma cell line:RAJI	10476-106I8	108.07	27.02	0.93	0.47	0.70	0.00	0.00	0.47
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	47.01	10.23	0.00	0.00	0.32	0.00	0.00	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	51.71	10.34	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	52.97	16.34	0.00	0.00	0.56	0.00	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	51.41	12.06	0.00	0.37	0.56	0.19	0.00	0.19
CD14+ Monocytes, donor3	11381-118B4	47.20	17.34	0.66	0.44	0.66	0.22	0.00	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	66.23	24.34	0.00	0.28	0.57	0.28	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	91.74	33.36	0.38	0.00	0.38	0.00	0.38	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	69.36	29.26	0.66	0.00	0.33	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	42.06	12.00	0.29	0.29	0.58	0.29	0.58	0.29
CD14+ monocytes - mock treated, donor2	11873-125C1	34.10	12.67	0.91	0.30	0.00	0.30	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	35.53	12.32	0.47	0.00	0.00	0.00	0.00	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	39.51	12.05	1.17	0.17	0.17	0.00	0.17	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	35.88	10.49	0.55	0.55	0.00	0.00	0.00	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	40.16	14.38	0.00	0.25	0.00	0.00	0.00	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	43.27	10.57	0.78	0.59	1.37	0.00	0.20	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	38.64	12.29	0.71	0.00	0.18	0.00	0.18	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	41.35	11.53	0.22	0.22	0.00	0.22	0.00	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	44.02	12.88	0.23	0.23	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	36.96	11.62	0.53	0.53	0.00	0.00	0.00	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	54.36	14.42	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	39.27	12.05	1.04	0.45	0.45	0.15	0.30	0.45
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	32.93	12.57	0.20	0.40	0.60	0.00	0.20	0.40
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	25.19	6.04	0.42	0.21	0.21	0.00	0.21	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	50.56	13.73	0.46	0.00	1.14	0.23	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	49.99	11.08	0.45	0.23	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	38.85	14.40	0.44	0.00	0.44	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	59.45	13.45	1.08	0.27	0.00	0.27	0.27	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	50.24	17.10	0.52	0.17	0.17	0.00	0.00	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	56.81	16.83	0.84	0.00	0.00	0.00	0.84	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	38.40	10.84	0.37	0.73	0.18	0.18	0.18	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	28.89	10.92	0.00	0.00	0.35	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	37.29	9.65	0.44	0.00	0.00	0.44	0.44	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	36.79	11.16	0.70	0.52	0.35	0.00	0.52	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	31.22	14.12	1.12	0.74	0.00	0.00	0.37	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	45.70	14.01	0.22	0.00	0.22	0.00	0.22	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	58.97	30.30	0.41	0.00	0.41	0.41	0.41	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	40.80	12.98	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	31.55	9.98	0.23	0.00	0.00	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	29.21	5.23	0.00	0.00	0.00	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	38.81	6.47	0.00	0.23	0.23	0.00	0.00	0.46
CD14+CD16+ Monocytes, donor3	11912-125G4	29.03	6.50	0.00	0.00	0.00	0.43	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	52.17	13.24	0.16	0.00	0.31	0.00	0.00	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	49.08	8.91	0.17	0.35	0.00	0.00	0.00	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	67.78	13.60	0.45	0.22	0.22	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	44.66	6.89	0.00	0.00	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	39.30	7.47	0.00	0.22	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	34.32	6.32	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	16.26	4.06	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	16.95	4.75	0.68	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	13.46	6.21	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	28.78	7.46	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	32.70	8.58	0.00	0.54	0.00	0.00	0.00	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	23.87	4.91	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	20.39	6.27	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	17.14	2.64	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	11.51	4.93	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	22.49	3.63	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	13.13	3.53	0.00	0.00	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	10.91	4.04	0.00	0.00	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	11.59	3.99	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	47.19	7.03	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	52.25	7.87	0.00	0.56	0.00	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	33.44	12.40	0.00	0.00	0.00	0.00	0.00	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	40.36	13.75	0.00	0.00	0.00	0.23	0.00	0.00
CD4+ T Cells, donor1	11225-116C1	36.42	4.28	0.00	0.00	0.00	0.00	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	31.23	1.84	0.00	0.00	0.00	0.00	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	28.36	4.57	0.61	0.00	0.30	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	19.91	3.32	0.51	0.26	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	27.18	4.27	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	24.15	6.61	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	10.90	2.84	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	10.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	6.59	6.59	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	46.24	8.82	0.72	0.29	0.00	0.00	0.14	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	27.79	7.46	0.34	0.17	0.17	0.00	0.00	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	31.76	8.22	0.16	0.32	0.32	0.00	0.16	0.16
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	11.21	1.79	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	9.78	2.10	0.35	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	18.92	3.52	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	62.40	10.96	0.00	0.42	0.42	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	38.23	14.54	0.42	0.00	0.21	0.00	0.00	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	44.77	13.37	0.33	0.33	0.00	0.00	0.67	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	19.31	3.81	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	20.90	3.22	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	14.35	5.38	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	69.35	13.54	0.00	0.37	0.19	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	45.92	9.31	0.00	0.87	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	55.27	11.14	0.42	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	18.71	1.52	0.00	0.00	0.00	0.00	0.00	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	11.26	1.30	0.43	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	20.48	3.92	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	21.28	7.92	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	21.23	5.54	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	16.75	8.37	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	37.94	6.92	0.00	0.00	0.28	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	35.83	10.06	0.25	0.00	0.25	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	40.04	3.08	1.54	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	29.72	5.01	0.36	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	26.31	5.54	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	56.31	15.39	0.98	0.00	0.00	0.33	0.00	0.65
CD8+ T Cells, donor2	11307-117C2	51.81	13.14	0.38	0.00	1.50	1.13	0.00	0.00
CD8+ T Cells, donor3	11383-118B6	37.12	10.86	0.25	0.25	0.25	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	38.31	19.73	0.46	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	39.78	17.97	0.00	0.48	0.00	0.00	0.24	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	49.52	15.32	0.55	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	32.42	12.61	0.60	0.60	0.00	0.00	0.30	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	44.88	16.08	0.00	0.48	0.00	0.00	0.00	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	40.25	20.01	0.00	0.23	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	33.68	12.60	0.22	0.00	0.22	0.00	0.00	0.43
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	31.32	12.90	0.00	0.00	0.00	0.00	0.26	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	35.41	14.07	0.23	0.23	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	35.32	14.79	0.00	0.30	0.30	0.60	0.30	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	36.31	21.21	0.29	0.00	0.29	0.29	0.29	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	34.64	21.58	0.53	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	29.77	23.20	0.88	0.00	0.00	0.88	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	35.98	34.61	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	29.83	25.36	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	38.18	17.65	0.36	0.00	0.00	0.36	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	45.17	18.13	0.00	0.00	0.29	0.00	0.00	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	45.96	14.85	0.24	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	37.39	14.26	0.95	0.32	0.00	0.00	0.00	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	40.29	19.38	0.00	0.62	0.00	0.00	0.00	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	33.98	18.27	0.00	0.32	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	30.60	14.53	0.38	0.00	0.38	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	27.98	19.71	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	35.55	12.10	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	35.33	22.48	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	29.38	24.48	0.00	0.00	0.00	0.70	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	33.06	20.04	0.00	0.00	0.00	0.00	0.00	1.00
Cardiac Myocyte, donor1	11525-119I4	274.16	63.97	0.00	7.31	0.00	1.83	5.48	0.00
Cardiac Myocyte, donor2	11605-120I3	120.06	38.54	1.48	1.98	0.99	0.99	0.00	0.49
Cardiac Myocyte, donor3	11686-122I3	110.39	37.57	0.21	0.32	0.84	0.11	0.00	0.21
Chondrocyte - de diff, donor1	11261-116G1	153.92	58.59	1.04	0.00	0.35	0.00	1.04	0.69
Chondrocyte - de diff, donor2	11338-117F6	133.98	52.24	0.00	0.36	0.36	0.00	0.00	0.36
Chondrocyte - de diff, donor3	11410-118E6	117.31	49.84	0.34	1.48	2.16	1.93	1.25	1.14
Chondrocyte - re diff, donor2	11339-117F7	534.47	188.90	6.27	0.90	0.00	1.79	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	185.22	106.36	2.43	0.81	0.81	0.40	0.00	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	75.63	16.53	0.46	0.34	0.34	0.23	0.11	0.23
Ciliary Epithelial Cells, donor2	11323-117D9	83.15	24.16	1.07	0.64	0.86	0.43	0.43	0.64
Ciliary Epithelial Cells, donor3	11399-118D4	92.39	32.66	0.97	1.24	0.97	0.53	0.35	0.44
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	109.58	30.81	0.37	0.28	0.37	0.83	0.28	0.28
Corneal Epithelial Cells, donor1	11526-119I5	61.04	14.93	0.00	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	55.74	17.06	0.00	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	41.67	19.68	0.26	0.00	0.26	0.26	0.26	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	44.25	13.04	0.00	0.17	0.33	0.17	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	47.94	13.88	0.00	0.32	0.00	0.00	0.00	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	44.86	3.45	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	27.65	12.63	0.54	0.43	0.32	0.22	0.22	0.32
Dendritic Cells - plasmacytoid, donor1	11228-116C4	334.13	65.94	0.34	0.34	0.00	0.00	0.00	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	246.78	48.97	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	241.00	45.01	0.00	0.97	0.00	0.48	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	65.04	16.84	0.00	0.33	0.33	0.00	0.17	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	59.85	18.19	0.00	0.00	0.00	0.00	0.00	1.17
Endothelial Cells - Aortic, donor2	11340-117F8	93.04	26.30	0.57	0.28	0.57	0.00	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	81.39	21.63	0.79	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	81.15	28.51	0.00	1.16	0.58	0.58	0.87	0.58
Endothelial Cells - Artery, donor2	11341-117F9	79.99	28.47	0.71	2.35	2.35	0.47	0.47	0.24
Endothelial Cells - Artery, donor3	11413-118E9	59.78	21.74	1.23	0.00	0.18	0.18	0.18	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	70.49	22.39	0.00	0.00	0.00	0.22	0.22	0.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	89.76	20.99	0.30	0.30	0.30	0.00	0.00	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	118.12	31.29	0.56	0.00	0.56	0.00	0.00	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	54.97	10.10	0.00	0.30	0.00	0.30	0.00	0.59
Endothelial Cells - Microvascular, donor2	11342-117G1	46.34	11.45	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	34.03	8.51	0.14	0.57	0.71	0.43	0.14	0.28
Endothelial Cells - Thoracic, donor1	11266-116G6	86.83	28.01	0.00	0.80	0.40	0.00	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	138.89	36.16	0.52	1.05	2.62	0.52	1.05	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	133.56	34.04	0.75	0.37	1.12	0.50	0.50	0.25
Endothelial Cells - Umbilical vein, donor2	11324-117E1	82.99	31.50	0.43	1.09	0.22	0.43	0.43	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	96.60	33.34	0.61	0.24	0.49	0.24	0.00	0.24
Endothelial Cells - Vein, donor1	11267-116G7	37.54	9.10	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	52.39	10.48	0.00	0.70	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	53.70	17.90	0.63	0.16	0.16	0.31	0.00	0.16
Eosinophils, donor1	12244-129H3	15.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	61.06	6.60	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	64.20	21.40	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	71.59	18.32	0.49	0.00	0.49	0.00	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	47.84	4.16	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	101.40	60.35	1.64	1.64	0.00	0.00	0.00	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	41.17	18.07	0.99	0.55	0.00	0.11	0.11	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	5.74	3.03	0.00	0.11	0.00	0.11	0.00	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	128.68	50.57	0.73	0.49	1.58	1.21	0.73	0.73
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	280.72	93.89	1.09	0.55	0.68	0.41	0.55	0.14
Fibroblast - Aortic Adventitial, donor2	11326-117E3	105.68	47.14	2.85	1.27	2.64	1.27	1.79	1.05
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	357.29	148.61	4.22	3.95	2.11	1.58	1.58	1.05
Fibroblast - Aortic Adventitial, donor3	11401-118D6	102.32	42.19	2.33	2.33	2.66	0.33	0.00	0.33
Fibroblast - Cardiac, donor1	11268-116G8	56.25	27.67	0.45	0.00	0.45	0.00	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	130.37	44.72	1.52	0.00	0.00	0.76	0.76	0.00
Fibroblast - Cardiac, donor3	11417-118F4	102.04	45.42	1.42	1.73	1.42	2.52	0.32	0.79
Fibroblast - Cardiac, donor4	11452-119A3	174.89	57.29	0.00	0.30	0.30	0.00	0.61	0.00
Fibroblast - Cardiac, donor5	11456-119A7	80.58	30.96	1.14	0.63	0.38	1.14	0.38	0.00
Fibroblast - Cardiac, donor6	11460-119B2	86.11	29.11	0.91	0.61	0.45	0.91	0.45	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	245.74	61.37	0.67	1.21	0.13	0.40	0.27	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	152.29	45.30	1.73	0.86	0.43	1.73	0.43	0.86
Fibroblast - Choroid Plexus, donor3	11653-122E6	124.51	38.08	0.00	4.39	1.46	1.46	0.00	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	146.69	40.13	0.23	0.00	0.00	0.23	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	202.17	65.64	1.02	1.36	0.85	0.00	0.17	0.00
Fibroblast - Dermal, donor1	11269-116G9	85.93	28.88	0.47	0.47	2.11	0.47	0.00	0.23
Fibroblast - Dermal, donor2	11346-117G5	97.64	21.70	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	77.37	30.10	0.85	0.97	0.60	0.60	0.97	0.60
Fibroblast - Dermal, donor4	11450-119A1	71.33	25.55	1.24	0.57	0.34	0.45	0.90	0.23
Fibroblast - Dermal, donor5	11454-119A5	81.99	30.88	0.87	1.22	0.17	0.52	0.17	0.52
Fibroblast - Dermal, donor6	11458-119A9	102.16	31.51	0.65	1.62	0.65	1.14	0.16	0.00
Fibroblast - Gingival, donor1	11237-116D4	208.02	67.26	0.42	0.42	0.83	0.21	0.21	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	175.54	78.86	3.41	0.79	0.52	0.52	0.79	0.00
Fibroblast - Gingival, donor2	11318-117D4	144.04	49.95	2.37	3.29	3.56	2.37	0.92	1.45
Fibroblast - Gingival, donor3	11394-118C8	149.77	63.72	2.03	0.58	1.35	0.77	0.68	0.10
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	165.18	76.88	0.00	0.00	1.04	3.12	1.04	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	114.36	43.52	3.70	1.41	3.00	1.94	1.41	0.70
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	207.03	79.35	2.03	0.62	0.94	0.47	0.78	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	184.72	69.37	0.81	0.68	0.14	0.95	0.14	0.00
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	122.80	46.93	0.00	0.35	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	204.60	92.57	1.17	0.88	0.88	0.00	1.17	0.58
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	247.07	90.67	1.64	0.68	0.68	0.00	0.27	0.55
Fibroblast - Gingival, donor8 (control)	11926-125H9	193.50	86.44	1.65	0.66	0.77	0.55	0.22	0.22
Fibroblast - Gingival, donor9 (control)	11927-125I1	169.48	65.89	1.47	0.29	0.44	0.29	0.00	0.00
Fibroblast - Lung, donor1	11270-116H1	65.25	9.52	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	104.45	37.30	1.49	1.49	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	100.66	38.41	0.42	1.06	1.27	1.06	0.42	0.63
Fibroblast - Lymphatic, donor1	11506-119G3	473.16	104.96	0.00	0.83	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	137.07	64.34	2.80	1.40	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	89.84	28.55	0.56	0.28	0.28	1.12	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	390.14	112.45	0.00	0.00	0.41	0.41	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	171.75	59.91	0.00	3.99	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	131.04	113.17	0.00	0.00	0.00	0.00	5.96	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	149.55	48.88	1.16	0.39	0.39	0.19	0.39	0.78
Fibroblast - Periodontal Ligament, donor2	11319-117D5	174.13	62.64	3.34	3.34	2.28	2.28	1.06	0.76
Fibroblast - Periodontal Ligament, donor3	11395-118C9	274.47	82.31	0.00	0.92	0.31	0.31	0.61	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	166.01	82.05	1.53	0.76	1.14	1.14	0.38	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	138.77	52.38	1.89	1.62	2.70	3.51	1.89	0.81
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	107.74	58.68	0.70	1.04	1.39	0.23	0.58	0.46
Fibroblast - Pulmonary Artery, donor1	11250-116E8	106.66	37.58	0.44	0.66	0.33	0.44	0.66	0.55
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	352.74	92.65	1.22	0.61	0.41	0.41	0.41	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	140.99	54.79	0.67	0.67	1.34	0.67	0.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	97.26	39.93	0.40	0.00	1.58	0.79	0.40	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	654.48	239.33	5.75	3.97	2.78	3.57	1.79	1.19
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	145.11	57.19	1.07	0.71	0.18	0.36	0.36	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	164.57	61.29	0.79	1.18	0.20	0.00	0.59	0.39
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	401.64	158.25	1.81	3.01	0.90	1.50	1.20	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	192.26	74.59	1.94	0.76	0.54	0.11	0.00	0.00
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	329.25	141.72	3.29	2.28	0.76	1.27	2.02	0.76
Fibroblast - skin normal, donor1	11553-120C5	184.26	58.41	0.33	0.98	0.16	0.33	0.16	0.49
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	1015.97	359.91	4.81	1.40	3.41	1.00	1.80	2.21
Fibroblast - skin normal, donor2	11561-120D4	204.74	73.34	1.81	1.11	0.50	0.60	0.50	0.10
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	429.18	141.75	2.42	2.72	1.81	0.60	0.91	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	177.12	63.13	0.91	0.50	0.58	0.33	0.25	0.33
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	199.84	65.13	2.22	0.68	0.34	0.34	0.68	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	388.86	136.63	5.25	2.96	1.64	1.31	1.31	0.66
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	143.27	52.62	1.07	0.64	0.21	0.64	0.75	0.11
Fibroblast - skin walker warburg, donor1	11554-120C6	184.20	62.92	0.84	0.67	1.35	0.34	0.51	0.34
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	68.69	34.19	1.25	0.78	0.78	0.47	0.78	0.94
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	132.96	22.16	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	45.32	21.79	0.00	0.00	0.00	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	139.21	27.39	0.52	0.35	0.17	0.00	0.35	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	138.19	35.65	0.26	0.00	0.26	0.00	0.00	0.52
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	128.78	32.71	0.51	0.00	0.77	0.00	0.26	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	61.24	19.14	0.00	0.77	0.00	0.00	0.77	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	56.15	17.23	0.00	0.00	0.00	0.00	0.64	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	90.14	31.38	1.43	0.29	0.29	0.29	0.29	1.71
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	21.78	6.89	0.28	0.55	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	76.03	33.56	0.91	0.46	0.23	0.23	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	75.09	23.18	1.19	0.59	1.39	0.79	0.20	0.40
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	25.64	12.16	0.26	0.26	0.26	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	28.37	13.70	0.33	0.00	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	65.01	15.92	0.44	0.00	0.00	0.88	0.44	0.88
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	66.42	26.71	0.42	0.28	0.14	0.28	0.14	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	51.23	21.43	0.49	0.25	0.99	0.49	0.12	0.25
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	56.95	19.34	0.27	1.07	1.07	0.81	0.27	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	54.39	21.81	0.62	0.87	0.50	0.00	0.25	0.37
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	55.37	20.21	0.42	0.14	0.69	0.69	0.28	0.14
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	59.97	21.35	1.42	0.81	1.02	0.41	0.00	0.41
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	54.76	19.40	0.68	0.46	1.14	0.23	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	49.58	18.56	0.50	0.62	0.62	0.75	0.37	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	68.41	24.92	0.00	0.00	0.22	0.66	0.44	0.66
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	57.91	22.46	0.89	0.30	0.89	0.59	0.00	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	50.39	19.87	0.16	0.48	0.48	0.32	0.16	0.16
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	65.24	25.25	0.67	0.45	0.00	0.22	0.45	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	61.50	19.36	0.00	1.01	2.42	0.60	0.40	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	51.23	21.71	0.17	0.34	0.51	0.17	0.68	0.17
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	138.06	38.75	0.53	0.09	0.44	0.18	0.09	0.18
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	122.47	38.50	0.21	0.10	0.10	0.00	0.21	0.31
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	108.61	36.20	0.51	0.17	0.34	0.00	0.17	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	66.72	28.11	0.55	0.33	0.55	1.00	0.11	0.11
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	112.65	32.70	0.42	0.25	0.58	0.42	0.25	0.25
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	106.99	36.14	0.00	0.41	0.20	0.41	0.00	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	74.27	28.26	0.41	0.83	1.03	1.03	0.62	0.21
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	68.37	32.74	0.35	0.46	0.81	0.69	0.35	0.58
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	70.71	28.18	0.33	0.17	1.17	0.67	0.17	0.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	61.94	23.59	0.00	0.44	0.66	0.66	0.66	0.66
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	80.31	34.19	0.86	1.11	0.98	0.86	0.37	0.49
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	63.70	24.31	0.65	0.65	0.81	0.00	0.00	0.49
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	87.23	35.60	0.96	0.96	0.64	0.96	0.64	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	65.66	29.47	0.76	0.66	0.47	0.85	0.09	0.47
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	65.01	27.68	0.32	0.16	0.79	0.16	0.32	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	79.06	29.80	0.61	1.22	2.13	1.22	0.30	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	69.94	32.62	0.94	0.94	1.46	0.21	0.31	0.42
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	77.94	32.49	1.32	0.22	1.10	1.10	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	70.98	25.25	0.28	1.12	0.84	1.12	0.00	0.84
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	87.31	43.05	0.74	0.83	0.19	0.19	0.09	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	75.41	30.22	0.80	0.27	0.27	1.07	1.34	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	70.99	25.86	0.61	0.77	1.07	0.46	0.46	0.61
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	72.15	33.81	0.26	0.26	1.30	0.91	0.52	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	92.98	40.93	0.00	0.54	0.27	0.27	0.81	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	132.55	57.52	1.11	0.92	2.95	1.66	0.37	1.11
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	162.29	62.28	1.32	1.32	3.73	1.54	0.22	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	247.94	100.17	1.98	0.99	2.98	1.98	0.00	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	157.50	56.72	0.66	0.92	2.90	0.92	0.53	0.26
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	122.26	43.58	1.41	0.81	3.03	1.01	0.40	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	352.27	111.58	0.25	0.00	1.78	0.25	0.00	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	79.82	17.92	0.80	0.80	0.00	0.20	0.00	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	58.86	21.11	0.15	0.62	0.46	0.62	0.46	0.46
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	67.92	25.37	1.02	0.82	0.20	0.00	0.00	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	65.72	18.46	0.00	0.31	0.31	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	54.82	16.11	0.00	0.28	0.00	0.00	0.28	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	59.96	17.06	0.46	0.92	0.00	0.00	0.00	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	76.72	24.75	4.95	2.47	2.47	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	57.63	23.60	0.00	0.39	1.16	0.39	0.39	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	78.62	25.67	0.00	1.60	1.60	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	64.34	27.82	0.00	0.00	1.74	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	64.44	20.51	0.65	0.98	0.33	0.33	0.00	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	81.12	25.12	0.00	1.24	0.41	0.82	2.06	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	73.31	43.32	0.00	0.00	3.33	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	74.11	23.77	1.12	1.96	0.84	0.28	0.28	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	88.90	23.86	1.31	0.33	0.65	0.33	0.00	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	85.56	33.55	0.00	0.00	0.84	0.00	1.68	1.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	81.11	31.49	0.64	1.27	0.95	0.32	0.32	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	82.88	29.21	0.68	0.34	0.34	0.34	0.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	79.35	18.79	0.00	0.00	0.00	2.09	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	77.31	23.48	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	71.33	25.16	0.00	0.89	0.30	0.59	0.00	0.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	62.68	25.41	0.00	5.08	1.69	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	99.00	32.31	0.00	2.07	1.24	0.41	0.83	0.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	70.19	29.00	0.46	1.61	0.00	0.00	0.46	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	94.83	26.34	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	78.04	25.76	0.38	1.54	0.38	0.38	0.38	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	79.86	25.75	0.65	0.33	0.00	0.33	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	44.81	22.74	0.67	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	80.91	27.74	1.16	1.16	0.77	0.39	0.77	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	138.65	49.64	0.68	1.37	1.37	0.68	0.00	1.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	84.48	49.70	0.00	2.48	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	56.15	28.78	0.47	0.00	0.47	0.94	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	81.47	33.80	0.00	0.60	0.00	1.21	1.21	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	71.72	36.62	0.00	1.02	0.51	0.51	0.00	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	71.79	28.72	2.39	1.20	0.40	0.00	1.20	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	84.86	35.03	1.48	0.99	0.00	0.00	0.49	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	101.52	47.22	1.18	1.18	1.18	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	65.93	22.17	0.58	1.17	0.58	1.17	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	91.29	32.04	1.32	0.44	0.44	1.32	0.44	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	82.23	27.13	0.85	2.54	0.85	0.00	0.85	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	53.13	22.09	0.60	0.60	1.19	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	63.08	19.90	0.49	0.00	0.00	1.46	0.49	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	156.36	69.62	1.14	0.00	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	181.71	62.79	1.25	4.99	5.82	4.57	1.25	0.83
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	65.22	31.48	0.00	0.00	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	114.18	34.57	0.32	1.90	1.90	0.63	0.63	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	70.18	32.17	0.00	1.25	0.84	0.84	0.84	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	44.10	19.96	0.12	0.70	0.70	0.46	0.46	0.23
Hep-2 cells mock treated, biol_rep2	11899-125E9	52.67	23.63	0.34	0.34	1.01	0.51	0.17	0.51
Hep-2 cells mock treated, biol_rep3	11900-125F1	47.55	22.30	0.46	0.68	1.14	0.46	0.68	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	50.28	20.33	0.44	0.77	0.87	1.20	0.22	0.44
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	55.02	30.09	0.64	0.43	0.21	0.21	0.64	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	48.01	26.05	0.00	0.65	0.22	1.08	0.22	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	38.23	14.07	0.37	1.00	1.12	0.75	0.50	0.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	36.03	15.10	0.34	0.51	0.51	0.17	0.34	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	34.92	16.02	1.60	0.32	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	70.51	21.27	0.56	1.68	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	138.06	51.07	2.60	2.16	0.87	0.87	0.87	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	50.23	13.22	0.00	2.64	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	296.29	97.00	0.35	0.00	0.71	0.00	0.35	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	238.30	95.17	0.73	1.45	2.91	1.45	0.73	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	90.57	33.39	0.52	1.57	1.22	1.40	0.35	0.70
Hepatocyte, donor1	11523-119I2	399.50	185.22	4.84	6.05	2.42	1.21	0.00	1.21
Hepatocyte, donor2	11603-120I1	412.62	154.06	4.31	1.08	1.08	3.23	0.00	2.15
Hepatocyte, donor3	11684-122I1	197.56	101.85	1.23	5.52	0.61	0.61	0.61	3.07
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	23.50	4.57	0.00	1.31	0.00	0.00	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	508.79	137.03	3.85	3.32	3.50	1.40	1.40	1.05
Iris Pigment Epithelial Cells, donor1	11530-119I9	93.71	30.32	0.14	0.00	0.14	0.55	0.41	0.27
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	6.37	6.37	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	6.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	12.46	2.77	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	10.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	23.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	2.56	2.56	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	4.57	4.57	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	16.24	1.62	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	5.00	1.67	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	21.78	10.89	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	15.88	3.97	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	14.41	3.33	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	10.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	10.71	3.78	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	10.83	3.09	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	29.27	14.63	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	9.69	5.81	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	6.44	3.22	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	15.48	6.52	0.00	0.00	0.00	0.00	0.00	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	13.43	4.20	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	14.47	8.84	0.00	0.00	0.80	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	14.77	2.77	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	15.08	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	10.86	2.36	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	3.63	4.53	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	11.84	3.23	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	7.62	1.27	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	14.67	4.46	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	14.58	5.47	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	19.99	3.57	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	3.32	13.27	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	20.85	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	9.26	4.01	0.31	0.31	0.00	0.31	0.00	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	8.78	3.51	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	12.57	6.29	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	13.91	6.26	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	2.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	3.24	9.73	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	10.46	6.98	0.87	0.00	0.00	0.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	6.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	3.48	3.48	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	1.07	3.20	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	6.93	1.39	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	19.95	2.85	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	7.36	2.76	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	6.05	6.05	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	12.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	5.29	2.11	0.00	1.06	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	156.43	30.52	0.65	0.49	0.90	0.16	0.33	0.16
Keratinocyte - epidermal, donor2	11349-117G8	26.94	11.13	0.00	0.59	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	51.30	20.73	0.66	0.38	0.38	0.47	0.09	0.38
Keratinocyte - oral, donor1	11251-116E9	66.07	17.82	0.45	0.45	0.45	0.23	0.23	0.34
Keratocytes, donor1	11527-119I6	167.45	40.92	0.69	0.00	0.00	0.00	0.34	0.00
Keratocytes, donor2	11607-120I5	180.46	63.28	2.34	3.52	0.00	0.00	0.00	1.17
Keratocytes, donor3	11688-122I5	93.46	30.23	0.59	0.20	1.38	1.38	0.20	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	281.33	105.50	0.00	0.00	0.00	0.00	2.20	0.00
Lens Epithelial Cells, donor1	11529-119I8	42.07	18.34	1.08	0.00	1.08	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	34.60	9.34	0.00	0.00	0.00	0.12	0.00	0.12
Lens Epithelial Cells, donor3	11690-122I7	152.98	49.34	0.50	0.30	0.20	0.30	0.30	0.10
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	62.25	14.47	0.12	0.24	0.00	0.47	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	35.72	9.49	0.28	0.28	0.28	0.00	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	49.74	13.38	1.10	0.63	0.47	0.16	0.47	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	36.56	10.22	0.00	1.61	0.00	0.54	0.00	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	34.35	10.72	0.32	0.32	0.63	0.32	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	34.82	12.61	0.43	0.86	0.54	0.32	0.11	0.43
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	37.35	10.26	0.00	0.00	0.00	0.00	0.00	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	28.06	7.08	0.51	0.00	0.00	0.25	0.00	0.76
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	47.71	8.73	0.14	1.27	0.28	0.28	0.42	0.42
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	26.90	9.89	0.00	0.40	0.40	0.40	0.40	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	25.98	10.47	0.39	0.19	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	35.73	6.85	0.37	0.19	0.19	0.19	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	31.71	10.45	0.00	0.35	0.35	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	31.72	10.02	0.00	0.24	0.00	0.24	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	36.53	10.30	0.27	0.96	0.55	0.27	0.41	0.55
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	28.33	12.01	0.00	0.92	0.00	0.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	22.76	7.48	0.31	0.00	0.00	0.00	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	51.60	14.09	0.37	0.37	0.55	0.55	0.18	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	39.82	14.48	0.33	0.33	0.66	0.66	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	30.17	9.37	0.59	0.59	0.00	0.29	0.29	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	44.31	14.19	0.50	0.75	0.25	0.75	0.50	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	26.67	6.79	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	23.16	9.69	0.00	0.27	0.54	0.00	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	45.41	12.87	0.30	0.61	0.30	0.30	0.30	0.45
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	34.73	9.33	0.00	1.04	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	30.99	6.07	0.21	0.21	0.21	0.21	0.21	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	45.26	11.28	0.30	0.60	0.00	0.45	0.00	0.45
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	34.39	12.38	0.00	1.38	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	26.72	9.41	0.19	0.19	0.00	0.19	0.19	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	38.38	12.41	0.21	0.53	0.74	0.21	0.11	0.42
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	30.04	12.11	0.00	0.97	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	30.43	6.28	0.33	0.33	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	43.11	11.65	0.50	0.74	0.74	0.62	0.74	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	49.98	17.40	0.37	0.00	0.37	0.37	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	20.26	7.66	0.00	0.74	0.00	0.00	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	31.21	7.56	0.82	1.24	0.27	0.41	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	42.78	14.47	0.00	0.64	0.00	0.00	0.00	0.64
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	29.82	5.78	0.30	0.30	0.00	0.00	0.30	0.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	37.65	11.06	0.00	0.84	0.14	0.14	0.42	0.28
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	36.27	10.67	0.00	0.36	0.36	0.71	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	25.21	7.76	0.00	0.48	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	36.88	8.87	0.47	0.47	0.31	0.31	0.47	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	27.57	8.95	0.00	0.36	0.36	0.36	0.36	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	25.48	8.17	0.33	0.33	0.33	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	36.73	12.71	0.47	0.24	0.00	0.47	0.71	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	62.49	15.10	0.74	0.50	0.12	0.25	0.62	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	21.51	6.66	0.26	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	34.01	12.23	0.60	0.60	0.00	0.00	0.00	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	29.46	11.33	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	36.82	11.51	0.00	0.00	0.00	0.77	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	28.20	5.94	0.00	0.00	0.74	0.00	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	29.20	11.42	0.85	0.00	0.42	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	23.21	8.44	0.70	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	17.75	10.27	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	29.89	7.73	1.55	0.52	1.03	0.52	0.00	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	30.93	8.33	0.00	1.19	0.00	1.19	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	32.57	8.14	0.23	0.23	0.45	0.00	0.00	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	29.37	11.63	0.58	0.29	0.58	0.29	0.58	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	32.41	10.35	0.00	0.45	0.45	0.00	0.90	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	51.48	15.45	0.54	0.00	0.14	0.00	0.00	0.27
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	36.46	10.78	0.51	0.51	0.51	1.03	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	24.35	8.82	0.00	0.00	0.35	0.35	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	39.31	13.33	0.00	0.00	0.00	0.00	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	24.96	9.68	0.51	0.51	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	29.62	17.61	0.53	0.00	0.00	0.00	0.27	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	34.58	14.55	0.57	0.38	0.19	0.76	0.19	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	33.13	13.50	1.23	1.84	1.23	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	44.03	13.86	0.00	0.82	0.00	0.82	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	34.78	17.91	0.83	1.04	0.62	0.00	0.42	0.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	40.64	12.05	0.28	0.56	1.12	0.00	0.28	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	46.37	16.49	0.00	0.00	3.09	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	41.22	17.71	0.29	0.87	0.87	0.87	0.58	0.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	37.67	10.16	0.60	0.60	0.60	0.00	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	28.22	14.38	1.11	0.00	0.55	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	45.60	16.97	0.35	1.06	0.71	0.71	0.71	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	45.73	10.69	0.00	0.00	0.00	0.37	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	19.57	9.21	0.00	0.00	1.15	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	34.92	15.35	0.38	0.00	0.00	0.00	0.38	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	32.84	10.76	0.00	0.00	0.00	0.57	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	28.72	9.85	0.00	0.00	0.82	0.82	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	30.28	14.46	0.90	0.45	0.00	0.90	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	33.03	17.24	0.00	0.00	0.72	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	35.85	12.70	0.75	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	34.93	14.12	1.11	1.49	0.37	0.37	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	37.48	13.78	0.43	0.86	0.00	0.00	0.43	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	35.96	10.28	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	42.31	13.99	0.33	2.67	0.67	0.67	0.33	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	50.07	15.08	0.60	0.60	1.21	0.00	0.00	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	36.26	9.24	0.00	0.00	0.71	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	45.37	11.34	0.00	0.69	1.03	0.34	0.00	0.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	39.72	14.49	0.54	1.07	0.00	0.00	0.54	1.07
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	36.36	12.12	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	41.86	18.52	1.11	0.37	0.37	0.00	1.11	1.11
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	45.35	12.79	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	33.85	8.46	0.00	0.00	1.06	0.00	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	60.42	24.01	1.20	0.80	0.80	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	26.89	13.08	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	28.36	3.07	0.77	0.00	0.00	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	28.12	9.87	0.49	0.49	0.49	0.00	0.49	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	31.99	16.00	0.00	0.94	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	29.16	9.05	0.00	0.50	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	45.51	18.48	1.80	0.45	0.00	0.45	0.00	0.90
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	36.14	13.77	1.72	0.00	1.72	1.72	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	32.06	9.80	0.89	0.45	0.00	0.89	0.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	42.62	16.81	1.17	0.78	0.78	1.17	0.39	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	25.73	10.56	0.00	0.66	0.00	0.00	0.66	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	34.77	12.97	1.04	0.00	0.00	0.00	0.52	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	45.07	15.31	1.75	1.75	0.44	0.00	0.44	1.31
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	31.87	9.50	0.56	0.00	0.00	0.56	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	25.17	7.95	0.88	0.88	0.88	0.00	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	36.64	17.74	0.39	0.00	0.39	1.16	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	46.08	9.62	0.51	0.00	0.51	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	25.47	12.98	0.00	0.00	0.48	0.48	0.48	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	44.92	19.48	0.80	0.80	0.00	0.40	0.00	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	37.67	12.15	0.00	0.00	0.61	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	30.43	10.38	0.00	0.00	0.00	0.00	0.00	1.38
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	45.98	14.82	1.52	0.76	0.00	0.00	0.38	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	38.21	15.49	1.03	1.03	0.52	0.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	35.67	7.26	0.60	0.00	0.00	0.60	0.00	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	53.87	19.65	1.90	0.63	1.58	0.32	0.32	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	41.58	11.19	0.00	0.00	0.53	0.00	0.53	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	22.99	6.90	0.00	0.00	0.57	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	46.80	19.54	0.51	0.51	0.51	0.00	0.51	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	38.20	10.61	0.00	1.41	0.00	0.71	0.00	1.41
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	32.91	9.08	0.57	1.13	0.00	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	60.74	22.88	0.00	1.25	0.00	0.00	0.00	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	43.85	18.01	0.00	0.78	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	29.65	12.11	1.25	2.09	0.42	0.42	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	37.17	14.40	0.93	0.46	0.93	0.46	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	38.14	16.06	0.00	0.67	0.67	0.67	0.67	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	39.03	13.90	0.53	0.00	1.60	0.53	0.00	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	52.13	16.97	0.40	2.42	0.40	0.00	0.00	1.21
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	39.46	10.10	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	38.23	13.34	0.00	0.89	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	38.75	21.66	0.57	1.14	0.57	0.00	0.57	1.14
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	60.59	9.97	1.53	0.77	0.77	0.00	0.77	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	57.45	9.30	0.55	0.55	0.55	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	37.42	17.37	1.78	0.89	1.34	0.00	0.45	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	68.63	18.46	0.52	0.00	0.00	0.00	0.00	0.52
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	47.74	14.59	1.99	0.00	0.00	0.66	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	24.94	16.63	0.00	0.00	0.00	0.00	2.08	0.00
Macrophage - monocyte derived, donor1	11232-116C8	65.87	23.02	0.00	0.46	0.46	0.46	0.23	0.46
Macrophage - monocyte derived, donor2	11313-117C8	57.44	16.88	0.18	0.00	0.00	0.18	0.00	0.18
Macrophage - monocyte derived, donor3	11389-118C3	51.51	20.84	0.52	0.66	0.66	0.13	0.26	0.26
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	56.29	13.28	0.00	0.00	0.00	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	217.24	64.65	1.11	0.95	0.95	0.48	0.63	0.63
Mallassez-derived cells, donor3	11930-125I4	160.39	38.36	0.42	0.83	0.28	0.69	0.69	0.28
Mammary Epithelial Cell, donor1	11273-116H4	95.56	33.78	0.10	0.40	0.60	0.40	0.30	0.30
Mammary Epithelial Cell, donor2	11350-117G9	83.10	23.45	0.87	1.16	0.87	0.29	0.29	0.87
Mammary Epithelial Cell, donor3	11422-118F9	45.65	13.72	0.50	0.25	0.25	0.50	0.25	0.00
Mast cell - stimulated, donor1	11487-119E2	404.05	139.65	1.36	0.00	0.68	0.00	0.68	0.00
Mast cell, donor1	11563-120D6	170.43	51.26	0.22	0.00	0.32	0.22	0.11	0.22
Mast cell, donor2	11565-120D8	148.29	59.43	0.00	0.30	0.89	0.00	0.30	0.30
Mast cell, donor3	11566-120D9	188.43	62.13	1.13	0.00	0.68	0.23	0.23	0.00
Mast cell, donor4	11567-120E1	185.27	58.86	0.35	0.18	0.00	0.18	0.35	0.18
Mast cell, expanded and stimulated, donor5	11940-126A5	110.12	40.03	0.67	0.55	0.33	0.11	0.00	0.00
Mast cell, expanded and stimulated, donor8	11942-126A7	160.51	54.28	0.00	0.58	0.00	0.00	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	113.57	30.97	0.69	0.23	0.46	0.23	0.23	0.23
Mast cell, expanded, donor8	11941-126A6	142.43	45.02	0.84	0.17	0.17	0.00	0.33	0.00
Melanocyte - dark, donor1	11502-119F8	53.93	15.52	0.10	0.10	0.60	0.10	0.20	0.00
Melanocyte - dark, donor2	11582-120F7	107.98	44.30	0.69	2.08	1.38	1.04	0.35	0.35
Melanocyte - dark, donor3	11663-122F7	86.57	25.28	0.22	0.00	0.22	0.58	0.07	0.22
Melanocyte - light, donor1	11274-116H5	37.14	11.75	0.24	0.47	0.24	0.00	0.00	0.00
Melanocyte - light, donor2	11351-117H1	38.22	13.65	0.00	0.00	0.00	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	32.95	14.74	0.00	0.00	0.00	0.87	0.00	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	59.98	23.64	0.83	0.52	0.73	0.94	0.62	0.62
Melanocyte, donor2 (MC+2)	12739-135I3	103.81	30.66	0.27	1.88	0.54	0.81	0.27	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	60.27	18.21	0.54	0.54	0.27	0.00	0.27	0.27
Meningeal Cells, donor1	11493-119E8	162.64	38.83	0.62	0.00	0.00	0.12	0.12	0.00
Meningeal Cells, donor2	11573-120E7	202.47	78.35	1.76	1.32	0.88	1.32	0.88	0.00
Meningeal Cells, donor3	11654-122E7	128.12	30.48	0.49	0.41	0.65	0.08	0.00	0.16
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	141.72	37.64	0.86	0.57	0.29	0.57	0.57	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	124.78	48.50	0.91	0.10	0.40	0.10	0.30	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	113.02	42.05	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	134.74	51.02	0.00	0.00	0.00	1.31	2.62	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	83.24	29.42	1.44	0.72	0.72	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	130.87	46.17	0.64	0.21	0.21	0.64	0.00	0.42
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	117.12	42.72	0.50	0.50	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	262.60	63.51	0.66	0.44	0.00	0.44	0.44	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	138.81	41.64	0.00	0.00	0.00	0.00	0.00	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	169.21	51.97	1.02	0.61	0.41	0.41	0.82	0.61
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	209.84	69.39	0.69	0.42	0.28	0.28	0.42	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	294.03	75.46	0.37	0.74	0.37	0.74	0.37	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	211.97	80.00	1.32	0.66	0.92	0.26	0.66	0.79
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	263.21	72.40	2.08	0.89	0.30	0.59	0.30	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	198.52	74.74	0.00	0.00	2.34	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	244.63	96.06	0.00	0.64	1.28	0.64	1.92	1.28
Mesenchymal stem cells - adipose, donor0	11217-116B2	112.00	37.57	0.71	0.35	0.35	0.35	0.35	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	159.80	63.17	0.00	0.31	0.00	1.88	1.25	0.94
Mesenchymal stem cells - umbilical, donor0	11214-116A8	95.07	36.28	0.73	0.00	0.00	0.00	1.45	0.00
Mesothelial Cells, donor1	11247-116E5	85.65	28.37	0.80	0.00	0.27	0.00	0.00	0.27
Mesothelial Cells, donor2	12156-128G5	84.58	22.52	1.50	0.00	0.50	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	70.02	25.58	0.79	0.65	1.37	0.65	0.58	0.79
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	189.05	44.56	0.00	1.35	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	59.84	26.84	0.49	0.25	1.23	0.25	0.25	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	53.00	22.97	0.29	0.00	0.29	0.00	0.59	0.88
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	86.43	65.68	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	42.77	16.74	0.00	0.31	0.00	0.00	0.00	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	40.66	14.11	0.21	0.00	0.00	0.21	0.00	0.41
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	78.75	67.17	0.00	2.32	2.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	46.05	22.27	0.50	0.00	0.25	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	63.77	24.20	0.00	0.00	0.47	0.47	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	233.59	38.93	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	40.44	16.26	0.61	0.00	0.41	0.00	0.20	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	45.14	15.44	0.00	0.40	0.00	0.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	102.62	68.41	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	35.40	12.39	0.00	0.88	2.65	1.77	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	42.55	13.68	0.00	0.38	0.38	0.38	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	75.01	43.42	0.00	0.00	1.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	34.80	16.13	0.42	0.21	0.00	0.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	48.80	16.57	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	37.56	17.59	0.30	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	73.77	30.18	0.00	1.68	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	169.75	33.95	0.00	0.00	33.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	36.63	10.79	0.25	0.25	0.75	0.25	1.25	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	59.65	20.20	0.48	0.48	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	108.37	59.16	0.00	0.55	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	56.87	23.25	0.46	0.23	0.23	0.00	0.00	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	59.95	24.82	0.42	0.63	0.21	0.00	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	56.26	23.64	1.22	0.00	0.61	0.20	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	48.06	21.24	0.21	0.21	0.21	0.00	0.43	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	62.02	23.56	0.00	0.00	0.22	0.22	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	216.69	51.59	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	51.25	17.52	0.44	0.22	0.00	0.22	0.00	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	85.17	44.61	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	149.13	87.82	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	88.06	26.36	0.54	0.54	0.82	0.00	0.00	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	80.28	31.76	0.59	0.00	0.00	0.00	0.29	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	150.46	51.25	0.00	1.09	2.18	0.00	1.09	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	43.25	15.38	0.00	0.00	0.96	0.00	0.48	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	95.65	30.42	1.20	0.80	0.80	0.40	0.40	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	161.80	95.99	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	61.57	23.53	1.00	0.50	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	107.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	99.89	46.89	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	81.45	23.65	0.00	0.00	0.88	0.00	0.00	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	126.92	55.18	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	133.20	83.89	0.00	0.64	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	91.48	32.97	0.25	0.99	1.24	0.00	0.25	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	107.17	47.32	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	196.68	92.81	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	102.22	36.58	1.03	0.68	0.34	0.34	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	100.21	46.82	0.00	0.00	0.00	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	115.41	72.08	0.00	0.36	0.36	0.36	0.36	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	74.07	23.29	0.28	0.56	0.56	0.28	0.56	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	83.54	33.67	0.00	0.00	0.00	0.00	0.42	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	104.89	65.27	0.58	0.00	0.58	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	85.97	28.66	0.60	0.30	1.21	0.30	0.30	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	88.49	30.47	0.83	0.00	0.83	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	144.38	93.84	0.00	7.22	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	68.34	17.55	1.85	0.00	0.92	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	101.87	34.72	0.57	0.00	0.57	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	94.52	40.35	0.55	0.41	0.55	0.14	0.55	0.41
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	86.56	25.14	0.52	0.26	0.26	0.00	0.00	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	79.36	44.18	0.00	0.86	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	102.27	52.09	0.00	0.00	0.64	0.00	0.64	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	84.87	34.70	1.07	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	69.15	14.37	0.60	0.30	0.00	0.00	0.30	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	57.49	23.45	0.57	0.00	0.28	0.00	0.00	0.28
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	81.86	21.02	0.32	0.64	0.32	0.32	0.32	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	86.68	32.51	0.22	0.22	0.44	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	99.73	35.64	0.00	0.38	0.38	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	78.41	21.02	0.00	0.28	1.14	0.57	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	74.97	27.04	0.49	0.25	0.00	0.00	0.74	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	76.90	24.76	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	74.68	19.99	1.18	1.18	0.29	0.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	58.53	21.05	0.86	0.00	0.29	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	103.45	17.31	0.82	0.00	0.82	0.00	0.41	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	62.24	20.55	0.30	0.00	0.30	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	11.30	3.77	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	17.82	10.69	1.78	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	50.27	19.06	1.31	0.33	0.99	0.66	0.33	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	25.25	12.62	1.05	1.05	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	44.28	17.20	0.59	0.00	0.20	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	62.40	24.21	0.00	0.93	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	45.44	20.65	0.75	0.00	0.00	0.00	0.75	0.75
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	44.75	16.25	0.00	0.00	0.80	0.00	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	37.21	14.14	0.00	0.00	0.11	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	26.52	13.26	0.00	0.00	0.00	0.74	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	32.25	20.89	0.00	0.37	0.73	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	24.89	18.67	4.67	0.00	0.00	1.56	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	10.69	1.60	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	11.59	3.86	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	29.29	21.21	0.00	0.00	1.01	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	16.44	5.48	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	17.71	9.53	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	3.81	3.81	0.64	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	9.72	3.24	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	10.57	6.04	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	22.84	34.26	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	45.67	9.79	3.26	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	71.29	28.51	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	37.65	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	170.41	66.79	0.65	0.86	0.65	0.22	0.86	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	76.82	30.83	1.05	1.57	1.05	0.00	0.52	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	68.75	27.37	2.00	0.67	0.00	0.00	0.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	50.92	32.55	0.42	0.83	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	95.26	41.45	1.52	0.57	0.19	0.19	0.38	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	205.87	132.46	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	44.88	19.04	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	207.65	75.34	5.51	3.68	1.84	0.00	3.68	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	49.39	25.53	0.42	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	78.33	33.01	0.46	0.70	0.23	0.00	0.00	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	69.45	28.64	0.54	0.00	0.00	0.00	0.27	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	110.79	46.88	0.84	0.21	0.21	0.21	0.42	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	656.95	167.02	11.13	22.27	0.00	0.00	11.13	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	72.96	27.30	0.00	0.00	0.50	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	66.31	26.53	1.08	0.00	0.27	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	76.17	31.28	0.45	0.00	0.00	0.23	0.00	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	75.45	30.37	0.49	0.16	0.00	0.00	0.16	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	103.16	46.11	0.91	1.09	1.09	0.73	0.18	0.36
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	59.41	27.05	1.59	0.53	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	46.82	20.41	1.20	0.00	0.00	0.00	0.00	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	84.01	28.88	0.00	0.66	0.33	0.33	0.00	0.66
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	63.59	27.00	0.16	0.33	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	135.99	61.73	0.88	0.53	0.35	0.18	0.71	0.35
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	52.04	18.99	0.00	0.00	0.00	0.00	0.70	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	73.09	26.20	0.00	0.00	0.92	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	88.69	39.53	1.29	0.32	0.64	0.00	0.32	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	103.81	39.32	3.10	0.34	1.72	0.34	0.00	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	407.08	113.78	0.00	0.00	2.53	0.00	5.06	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	118.30	50.57	0.89	0.22	0.22	0.22	0.22	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	62.66	31.75	0.00	0.00	0.00	0.00	0.00	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	57.91	27.30	0.47	0.00	0.00	0.24	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	91.43	46.79	1.72	0.00	0.00	0.00	0.86	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	686.11	252.78	9.03	0.00	9.03	0.00	9.03	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	96.97	47.65	0.67	0.33	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	131.20	64.47	0.00	0.00	0.00	0.00	0.45	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	66.27	36.90	1.59	0.79	0.00	0.00	0.00	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	56.65	37.15	2.79	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	86.27	46.16	0.76	0.00	1.14	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	73.98	48.56	0.00	0.65	0.00	0.00	0.33	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	65.37	43.14	0.87	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	154.68	89.10	0.90	3.17	0.45	0.45	0.00	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	66.14	40.57	1.76	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	67.15	41.89	0.66	0.66	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	75.89	51.09	1.98	0.99	0.00	0.00	0.99	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	71.59	45.17	1.53	0.38	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	169.97	79.24	2.42	0.30	0.30	0.30	0.60	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	133.28	61.00	1.11	1.33	0.22	0.00	1.33	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	56.25	33.21	0.00	0.00	0.00	0.00	0.68	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	316.79	112.41	5.11	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	74.38	45.12	0.61	0.00	0.00	0.61	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	87.50	48.15	1.26	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	67.19	41.46	0.91	0.91	0.30	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	72.78	28.48	1.58	1.58	0.79	0.79	0.79	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	134.90	68.02	2.27	0.00	0.00	1.13	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	328.76	106.22	15.17	10.12	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	132.43	44.72	1.12	0.87	1.12	0.50	0.62	0.62
Myoblast, donor2	11322-117D8	137.32	48.71	3.45	2.88	3.64	3.45	2.11	0.58
Myoblast, donor3	11398-118D3	152.52	46.24	0.17	0.50	0.17	0.34	0.00	0.17
NK T cell leukemia cell line:KHYG-1	10777-110G3	31.81	22.91	0.29	0.15	0.15	0.15	0.15	0.15
Natural Killer Cells, donor1	11230-116C6	90.10	22.76	0.31	0.31	0.00	0.00	0.00	0.00
Natural Killer Cells, donor2	11311-117C6	63.33	17.49	1.51	0.60	0.60	0.60	0.90	0.60
Natural Killer Cells, donor3	11387-118C1	74.17	29.08	0.92	0.55	0.37	0.37	0.55	0.37
Neural stem cells, donor1	11275-116H6	79.12	12.70	0.73	0.00	0.00	0.00	0.00	0.00
Neural stem cells, donor2	11352-117H2	48.14	5.78	1.93	0.00	0.00	0.00	0.00	0.00
Neurons, donor1	11494-119E9	9.10	0.00	0.00	1.14	1.14	0.00	0.00	0.00
Neurons, donor2	11574-120E8	12.99	3.52	0.66	0.00	0.00	0.00	0.22	0.00
Neurons, donor3	11655-122E8	9.87	1.64	0.82	0.00	0.00	0.00	0.00	0.82
Neutrophils, donor1	11233-116C9	38.98	4.64	1.86	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	57.98	11.60	0.00	0.00	0.00	0.00	0.00	2.90
Neutrophils, donor3	11390-118C4	83.07	9.77	0.00	0.00	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	208.14	58.18	0.59	0.95	1.31	1.07	0.47	0.83
Nucleus Pulposus Cell, donor2	11409-118E5	86.28	28.00	0.65	0.98	1.30	0.65	0.33	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	65.98	22.46	0.40	1.00	0.00	0.40	0.20	0.00
Olfactory epithelial cells, donor1	11933-125I7	105.03	54.51	1.38	1.65	0.96	0.96	0.83	1.24
Olfactory epithelial cells, donor2	11934-125I8	133.02	63.98	3.33	3.04	4.34	3.33	1.01	1.16
Olfactory epithelial cells, donor3	11935-125I9	100.68	46.99	1.14	0.34	2.04	0.57	0.45	0.79
Olfactory epithelial cells, donor4	11936-126A1	145.02	74.80	0.78	0.88	0.58	1.07	0.49	0.68
Oligodendrocyte - precursors, donor1	11496-119F2	129.39	38.52	0.00	0.60	1.20	0.00	1.81	0.60
Osteoblast - differentiated, donor1	11276-116H7	142.51	68.06	1.06	0.43	0.00	0.00	0.21	0.21
Osteoblast - differentiated, donor2	11353-117H3	45.72	34.29	0.00	2.29	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	36.00	29.17	0.00	0.00	0.00	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	110.81	32.25	0.39	0.39	0.20	0.00	0.59	0.00
Osteoblast, donor2	11354-117H4	299.89	71.64	0.00	0.70	0.00	3.51	0.00	1.40
Osteoblast, donor3	11426-118G4	100.24	56.16	1.24	0.36	0.00	0.36	0.53	0.00
Pancreatic stromal cells, donor1	11249-116E7	191.55	62.17	1.26	1.43	0.93	1.18	0.76	0.67
Pericytes, donor1	11491-119E6	96.80	32.04	0.33	0.00	0.33	0.11	0.00	0.00
Pericytes, donor2	11571-120E5	79.00	29.88	0.45	0.91	0.91	0.91	0.00	0.00
Pericytes, donor3	11652-122E5	145.06	64.90	1.22	1.02	1.63	1.02	0.81	1.22
Perineurial Cells, donor1	11499-119F5	145.46	48.26	0.34	0.11	0.45	0.45	0.00	0.00
Perineurial Cells, donor2	11579-120F4	180.62	56.49	0.28	0.55	0.64	0.55	0.18	0.09
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	66.94	14.98	0.00	0.00	0.32	0.00	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	37.71	14.94	0.00	0.73	0.98	1.22	0.00	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	47.24	13.98	0.52	0.13	0.26	0.52	0.26	0.39
Placental Epithelial Cells, donor1	11278-116H9	63.62	18.42	0.00	0.00	0.00	0.24	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	97.58	33.27	0.00	0.00	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	70.48	34.16	0.00	0.39	0.79	0.39	0.98	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	47.15	29.43	0.95	0.63	0.32	0.00	0.00	0.32
Preadipocyte - breast, donor1	11467-119B9	142.94	42.96	0.19	0.56	0.38	0.00	0.38	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	270.45	110.43	1.17	0.13	1.17	0.13	0.00	0.13
Preadipocyte - breast, donor2	11328-117E5	90.06	46.83	2.25	0.68	2.70	0.23	1.35	1.13
Preadipocyte - omental, donor1	11468-119C1	169.53	53.07	1.39	0.75	0.75	0.43	0.32	0.21
Preadipocyte - omental, donor2	11329-117E6	152.33	51.50	0.44	0.00	0.44	0.00	0.44	0.00
Preadipocyte - omental, donor3	11403-118D8	125.06	67.33	1.43	0.86	2.58	0.72	0.86	0.57
Preadipocyte - perirenal, donor1	11469-119C2	66.93	23.62	0.98	0.00	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	86.30	26.10	0.31	0.00	0.00	0.31	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	173.89	69.77	3.01	4.60	4.78	4.43	3.72	0.71
Preadipocyte - subcutaneous, donor3	11428-118G6	130.27	57.05	0.34	1.19	2.38	1.36	1.02	0.68
Preadipocyte - visceral, donor1	11280-116I2	247.31	74.98	0.47	0.47	0.28	0.19	0.09	0.28
Preadipocyte - visceral, donor2	11357-117H7	187.75	68.11	1.38	4.60	3.68	5.06	1.38	0.46
Preadipocyte - visceral, donor3	11429-118G7	113.16	46.60	1.36	1.99	0.84	1.78	1.04	0.21
Prostate Epithelial Cells (polarized), donor1	11253-116F2	394.48	107.26	1.96	2.56	3.62	2.56	0.91	1.21
Prostate Epithelial Cells, donor2	11331-117E8	93.30	33.85	0.81	0.68	2.57	1.49	1.22	0.81
Prostate Epithelial Cells, donor3	11404-118D9	47.34	13.47	0.98	0.67	0.80	0.55	0.49	0.49
Prostate Stromal Cells, donor1	11254-116F3	204.11	74.83	1.82	1.48	2.16	1.03	0.46	1.14
Prostate Stromal Cells, donor2	11332-117E9	201.17	79.61	3.23	3.23	5.20	3.94	3.05	0.72
Prostate Stromal Cells, donor3	11405-118E1	140.67	67.78	1.77	1.77	2.29	1.98	1.98	0.52
Renal Cortical Epithelial Cells, donor1	11516-119H4	89.42	23.72	0.00	0.00	0.36	0.00	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	79.99	19.89	0.55	0.49	0.28	0.28	0.14	0.28
Renal Epithelial Cells, donor1	11517-119H5	72.53	15.72	0.51	0.51	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	79.67	25.61	0.00	0.00	2.13	1.42	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	96.55	18.10	0.32	0.32	0.11	0.11	0.21	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	51.74	19.06	0.68	0.00	0.00	0.68	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	59.84	18.46	0.54	0.40	0.00	0.40	0.13	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	97.68	42.18	1.33	1.55	1.11	1.11	0.44	1.33
Renal Glomerular Endothelial Cells, donor4	11783-124B1	107.14	39.93	0.67	0.00	0.00	0.00	0.67	0.00
Renal Mesangial Cells, donor1	11518-119H6	144.60	39.40	0.66	0.22	0.00	0.00	0.22	0.22
Renal Mesangial Cells, donor2	11598-120H5	97.18	35.11	0.63	0.00	1.25	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	61.86	23.03	1.39	0.55	0.28	0.28	0.00	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	140.65	34.89	0.54	0.00	0.00	0.00	0.27	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	70.00	35.00	0.84	0.42	0.00	0.84	0.00	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	76.75	21.60	0.58	0.19	0.58	0.19	0.19	0.39
Retinal Pigment Epithelial Cells, donor0	11215-116A9	52.37	14.26	0.00	0.26	0.26	0.26	0.00	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	78.74	17.34	0.57	0.00	0.00	0.00	0.00	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	47.34	11.32	0.00	0.00	1.03	1.03	0.00	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	64.73	7.78	0.00	0.00	0.25	0.00	0.00	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	261.12	92.74	0.67	0.94	0.40	0.67	0.40	0.80
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	173.32	58.07	0.00	0.89	0.00	0.00	0.89	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	107.87	22.57	3.85	3.30	1.10	0.55	1.10	1.10
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	289.45	77.15	1.74	0.58	0.58	1.16	0.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	182.30	49.41	1.30	1.17	0.13	0.39	0.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	121.05	42.80	1.39	1.59	1.59	1.19	0.99	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	221.07	54.43	0.45	0.33	0.22	0.22	0.33	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	181.48	54.58	2.11	1.36	0.74	1.98	1.12	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	127.62	40.21	1.75	1.75	2.33	1.28	0.93	1.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	199.93	61.71	2.08	3.00	1.39	1.39	1.16	2.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	110.21	32.31	0.55	0.96	0.41	0.27	0.41	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	129.64	40.54	1.66	2.87	3.63	1.21	1.06	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	185.64	39.78	0.00	0.36	0.18	0.00	0.00	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	110.17	32.85	0.57	1.00	0.72	0.72	0.29	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	122.77	38.63	1.29	1.61	1.50	1.18	0.64	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	142.06	42.26	1.11	1.99	0.22	0.00	0.44	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	104.57	34.03	0.38	1.53	0.57	0.76	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	129.22	42.76	0.84	1.40	1.30	0.56	0.75	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	302.53	64.83	0.94	0.75	0.19	0.38	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	120.10	42.07	0.53	0.80	0.66	0.40	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	157.01	51.40	2.34	2.04	2.82	2.63	0.97	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	154.10	45.64	0.57	1.72	1.15	0.57	0.95	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	109.36	38.45	0.53	0.64	0.53	0.64	0.53	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	150.80	45.13	0.84	2.80	1.68	1.12	1.12	1.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	188.16	51.78	1.03	2.22	1.03	1.54	0.68	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	108.85	37.20	0.36	0.36	0.36	0.36	0.36	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	138.45	40.71	1.59	1.84	2.21	0.74	0.49	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	168.17	51.98	0.67	1.88	0.94	1.48	0.54	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	120.30	29.48	1.42	1.65	0.47	0.24	0.24	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	128.37	43.25	2.58	2.78	2.78	0.99	0.99	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	179.83	53.78	0.94	0.94	1.40	1.17	0.70	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	104.92	34.01	0.62	0.41	0.41	0.21	0.21	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	156.17	41.81	1.99	3.54	1.55	1.55	1.33	0.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	158.13	54.52	0.21	0.84	0.42	1.04	0.63	0.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	127.45	37.68	0.81	0.81	0.13	0.94	0.67	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	155.82	54.32	0.34	0.68	0.51	0.68	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	170.43	58.61	0.77	0.96	0.00	1.35	0.77	1.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	124.31	35.25	1.20	1.03	0.17	0.52	0.69	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	133.47	44.72	0.82	0.69	0.55	0.27	0.55	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	161.05	50.24	1.97	2.46	1.97	2.30	0.99	1.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	127.31	37.67	0.68	0.34	0.17	0.34	0.17	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	154.62	52.52	1.33	2.07	1.78	1.48	0.59	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	204.98	61.84	0.80	0.80	0.27	0.27	0.27	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	123.20	31.25	0.41	0.83	0.28	0.41	0.14	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	161.20	36.91	1.67	2.14	0.95	0.24	0.71	0.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	290.22	80.21	1.61	1.61	2.02	1.21	0.60	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	117.53	28.91	0.85	0.94	0.19	0.38	0.66	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	126.12	46.12	1.40	2.10	1.05	1.05	1.75	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	134.18	45.33	0.30	0.60	0.91	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	116.02	33.17	0.61	0.73	1.22	0.24	0.86	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	430.98	93.01	0.44	0.73	0.73	0.29	0.15	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	143.59	28.60	0.61	0.61	0.61	0.61	0.00	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	106.39	24.41	0.60	0.60	0.30	0.00	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	168.51	48.40	1.58	1.13	1.36	1.13	0.45	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	230.05	67.40	2.40	3.00	1.80	1.20	1.50	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	204.50	41.92	1.53	0.71	0.00	0.47	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	167.55	53.79	2.77	0.64	0.85	0.43	0.43	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	219.36	61.90	1.20	1.20	1.20	0.60	0.60	0.00
Schwann Cells, donor1	11498-119F4	120.93	45.89	1.32	0.75	0.38	0.38	0.19	0.38
Schwann Cells, donor2	11578-120F3	54.44	10.21	0.00	3.40	3.40	6.80	0.00	0.00
Schwann Cells, donor3	11659-122F3	116.55	45.35	0.66	1.75	1.10	0.66	0.66	1.53
Sebocyte, donor1	11220-116B5	213.63	64.09	1.10	0.00	0.55	0.55	0.00	0.00
Sebocyte, donor2	11301-117B5	73.53	18.84	0.46	1.38	3.68	0.00	1.38	0.92
Sebocyte, donor3	11378-118B1	78.53	28.24	0.41	0.82	1.65	0.00	0.82	0.41
Sertoli Cells, donor1	11255-116F4	129.21	59.64	0.00	0.00	0.00	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	141.22	56.49	0.00	5.65	2.82	0.00	2.82	2.82
Skeletal Muscle Cells, donor1	11281-116I3	92.38	25.95	0.00	0.18	0.35	0.09	0.00	0.35
Skeletal Muscle Cells, donor2	11358-117H8	29.64	9.40	0.00	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	78.59	42.64	0.00	0.00	0.00	0.84	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	95.83	30.16	1.10	0.79	0.63	0.47	0.63	0.16
Skeletal Muscle Cells, donor5	11455-119A6	88.44	36.57	1.19	0.74	0.45	0.59	0.45	0.00
Skeletal Muscle Cells, donor6	11459-119B1	95.27	31.09	0.77	0.46	0.62	0.46	0.77	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	251.00	64.26	0.76	1.39	1.76	1.26	0.50	0.50
Skeletal Muscle Satellite Cells, donor2	11321-117D7	166.52	53.79	2.14	3.57	3.57	2.14	1.00	1.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	117.96	41.27	1.29	0.79	1.29	1.19	0.79	0.89
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	298.50	105.57	0.59	1.18	1.18	0.76	0.42	0.59
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	22.44	11.58	0.72	0.00	0.00	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	42.24	19.81	1.24	0.41	0.00	0.14	0.41	0.00
Skin - palm, donor1	10286-104F7	102.07	77.90	0.00	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	61.41	18.88	0.29	0.00	0.00	0.00	0.00	0.43
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	202.84	40.89	1.64	0.82	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	37.78	11.55	0.91	0.00	0.00	0.00	0.13	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	116.49	35.03	0.56	0.83	0.28	0.28	0.70	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	76.66	26.58	0.70	1.41	1.27	1.13	0.28	0.84
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	280.17	68.30	1.06	0.63	1.06	0.00	0.42	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	70.68	29.68	0.60	0.60	0.75	0.60	0.45	0.22
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	11.73	4.01	0.00	0.31	0.00	0.62	0.00	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	469.12	210.33	4.89	3.56	1.11	3.78	1.33	0.89
Smooth Muscle Cells - Aortic, donor0	11210-116A4	112.86	52.32	0.59	0.00	0.59	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	145.85	56.13	0.44	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	121.28	38.98	0.39	0.00	0.00	0.00	0.39	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	142.15	41.72	0.77	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	137.10	41.03	0.00	2.00	1.00	1.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	120.30	46.84	0.53	0.80	0.13	0.00	0.13	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	127.89	50.98	1.77	2.44	3.99	2.66	1.77	1.11
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	56.85	33.29	2.43	0.64	0.13	0.00	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	108.42	27.02	0.00	0.33	0.33	0.00	0.00	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	166.86	59.95	0.59	0.59	0.30	0.30	0.30	0.89
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	101.93	44.70	0.43	0.57	0.57	0.57	0.57	0.57
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	197.16	52.54	0.98	0.98	0.49	0.00	0.16	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	148.26	53.88	0.61	1.22	0.91	2.13	0.00	1.22
Smooth Muscle Cells - Carotid, donor1	11285-116I7	124.01	43.44	0.25	0.76	0.00	0.25	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	269.31	159.14	6.12	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	25.75	20.03	1.91	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	201.15	61.64	0.74	0.74	1.18	0.29	0.44	1.18
Smooth Muscle Cells - Colonic, donor2	11320-117D6	148.08	56.82	2.15	3.01	1.72	1.29	1.94	1.29
Smooth Muscle Cells - Colonic, donor3	11396-118D1	132.04	55.84	1.47	0.84	1.36	1.05	0.52	1.15
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	129.93	48.57	0.46	0.00	0.00	0.00	0.15	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	101.32	26.95	2.16	3.23	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	69.33	34.67	0.60	0.60	0.60	0.00	0.30	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	217.13	60.09	0.34	0.68	0.00	0.34	0.34	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	294.33	82.46	1.33	1.10	0.71	0.63	0.55	0.47
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	245.46	79.61	1.61	0.91	1.81	1.01	0.20	1.01
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	163.84	63.94	1.14	3.64	2.73	3.41	0.91	0.68
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	96.01	49.51	4.23	0.00	0.00	0.60	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	135.38	33.38	0.79	0.26	1.06	0.26	0.53	0.79
Smooth Muscle Cells - Prostate, donor1	11257-116F6	173.77	54.99	0.80	0.80	0.00	1.07	0.13	0.13
Smooth Muscle Cells - Prostate, donor2	11335-117F3	193.34	92.04	3.13	2.75	3.88	3.01	1.13	1.63
Smooth Muscle Cells - Prostate, donor3	11465-119B7	83.45	32.22	0.76	0.00	0.00	0.25	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	146.25	53.83	0.00	0.15	0.15	0.30	0.45	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	57.01	21.00	2.25	0.75	0.00	0.75	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	430.31	173.16	6.46	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	157.66	78.60	0.93	0.00	0.47	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	148.94	54.02	0.50	2.02	1.01	1.01	1.51	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	92.76	46.70	3.45	0.63	0.31	0.00	0.63	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	132.75	42.77	0.59	0.00	0.59	0.00	0.88	0.59
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	198.69	54.57	0.17	0.25	0.08	0.25	0.00	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	163.04	54.19	0.93	0.93	0.47	0.93	0.47	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	88.51	34.25	0.29	0.14	0.00	0.00	0.14	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	65.27	38.75	1.27	1.53	0.25	0.25	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	59.61	28.77	0.94	0.19	0.19	0.75	0.19	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	159.45	45.14	0.42	0.56	0.42	0.56	0.14	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	168.16	60.16	0.25	0.42	0.50	0.08	0.34	0.17
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	99.05	30.48	0.48	0.00	0.00	0.00	0.48	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	77.80	28.38	0.49	0.00	0.24	0.00	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	190.90	77.99	1.55	0.66	0.22	0.44	0.66	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	72.85	20.77	0.29	0.29	0.59	0.59	0.00	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	183.28	79.88	0.39	1.75	1.17	0.58	0.58	0.39
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	183.00	105.25	3.17	1.85	1.06	0.26	0.53	1.59
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	110.10	49.84	1.12	2.60	0.74	1.12	0.74	2.23
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	245.79	103.13	2.16	2.87	0.36	0.36	1.44	2.52
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	131.16	55.93	1.42	0.85	0.00	0.00	0.28	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	141.79	54.35	1.97	1.58	1.18	0.00	1.18	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	146.02	69.58	1.02	1.78	0.51	0.25	0.51	0.51
Smooth muscle cells - airway, control, donor2	11967-126D5	142.96	57.90	1.20	2.40	0.80	0.40	0.40	0.80
Smooth muscle cells - airway, control, donor3	11968-126D6	136.27	63.95	0.42	2.09	0.42	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	109.55	51.79	0.92	0.46	0.92	0.46	0.00	0.46
Synoviocyte, donor1	11291-117A4	226.56	95.10	1.01	0.67	2.02	0.17	0.67	1.18
Synoviocyte, donor2	11368-117I9	82.47	41.24	1.34	1.34	2.01	1.68	1.01	0.34
Synoviocyte, donor3	11440-118H9	81.99	32.39	0.89	1.12	0.89	0.89	0.89	0.67
Trabecular Meshwork Cells, donor1	11532-120A2	261.92	67.89	0.00	0.71	0.71	0.36	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	144.69	43.60	0.00	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	151.66	52.10	0.93	0.23	0.46	0.69	0.23	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	67.10	18.92	0.50	0.00	0.00	0.07	0.07	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	23.58	10.44	0.00	0.00	0.00	0.00	0.39	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	20.62	8.02	0.00	0.00	0.00	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	263.52	87.35	0.86	0.62	0.86	0.86	0.37	0.25
Urethra, donor2	10319-105A4	172.65	71.94	1.80	0.00	0.00	0.00	0.00	3.60
Urothelial Cells, donor1	11520-119H8	85.28	23.38	0.27	0.00	0.53	0.27	0.00	0.00
Urothelial Cells, donor2	11600-120H7	54.48	19.23	0.80	0.40	0.80	0.00	0.80	0.00
Urothelial Cells, donor3	11681-122H7	44.92	19.94	0.00	0.69	0.00	0.00	0.00	0.00
Urothelial cells, donor0	11216-116B1	108.10	32.77	0.67	0.00	0.45	0.45	0.22	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	40.93	4.45	0.00	0.00	0.89	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	37.17	7.15	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	28.75	5.48	0.68	0.00	0.00	0.68	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	46.83	9.99	0.00	0.34	0.00	0.00	0.00	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	41.25	4.65	0.00	0.58	0.00	0.58	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	42.69	8.33	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	40.38	7.34	0.00	0.00	0.00	0.00	0.00	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	29.21	5.48	0.91	0.91	0.91	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	40.46	17.15	0.62	0.25	0.25	0.12	0.37	0.12
Wilms' tumor cell line:HFWT	10597-108E3	29.04	7.92	0.00	0.00	0.00	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	59.49	20.11	0.00	0.28	1.12	0.28	0.00	0.56
achilles tendon, donor2	10292-104G4	101.26	49.60	2.07	2.07	0.00	0.00	2.07	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	30.59	7.39	0.00	0.25	0.00	0.25	0.25	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	61.76	19.27	0.23	0.23	0.00	0.23	0.00	0.23
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	40.12	15.79	0.00	0.12	0.12	0.00	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	29.66	8.98	0.27	0.00	0.82	0.00	0.27	0.27
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	54.25	13.49	0.28	0.84	0.00	0.28	0.84	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	42.08	13.75	0.63	0.00	0.42	0.00	0.00	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	49.81	20.69	0.54	0.54	0.54	0.27	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	60.81	15.86	0.00	0.00	0.44	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	100.86	28.59	2.45	0.41	1.23	0.00	0.82	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	39.61	18.64	0.78	0.78	0.00	0.00	0.00	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	25.21	8.65	0.37	0.92	0.00	0.00	0.37	0.18
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	101.41	50.71	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	36.25	8.83	0.46	0.00	0.00	0.46	0.23	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	30.55	10.36	0.00	0.00	1.04	0.26	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	44.71	9.35	0.29	0.88	0.88	0.29	0.29	0.88
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	51.59	20.45	0.00	0.46	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	31.26	8.64	0.00	0.41	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	11.05	7.67	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	28.59	9.39	0.43	0.43	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	27.90	7.58	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	30.09	10.11	0.00	0.24	0.24	0.00	0.24	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	14.70	6.24	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	35.69	14.01	0.00	0.33	0.33	0.00	0.33	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	78.04	31.59	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	61.02	20.72	0.38	0.38	0.38	0.00	0.38	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	52.34	17.45	0.00	0.00	0.00	0.00	0.00	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	88.10	50.61	0.00	1.87	0.00	0.00	0.00	1.87
adenocarcinoma cell line:IM95m	10796-110I4	76.54	33.21	0.94	0.00	0.24	0.24	0.00	0.24
adipose tissue, adult, pool1	10010-101C1	112.93	36.92	0.47	0.31	0.16	0.31	0.00	0.16
adipose, donor1	10184-103D4	31.08	10.56	0.00	0.00	0.59	0.00	0.00	0.00
adipose, donor2	10185-103D5	16.22	8.11	0.41	0.00	0.00	0.00	0.00	0.00
adipose, donor3	10186-103D6	83.59	51.73	0.82	0.54	0.00	0.00	0.00	0.00
adipose, donor4	10187-103D7	380.50	247.02	5.20	1.73	0.87	0.00	0.00	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	32.67	11.99	0.32	0.63	0.16	0.00	0.32	0.16
adrenal gland, adult, pool1	10081-102A9	54.57	21.83	0.00	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	83.78	28.15	0.40	0.00	0.40	0.53	0.67	0.40
alveolar cell carcinoma cell line:SW 1573	10708-109H6	52.52	22.15	0.36	0.00	0.36	0.00	0.00	0.00
amniotic membrane cells, donor1	12235-129G3	103.87	51.01	0.70	0.23	0.46	0.23	0.23	0.23
amniotic membrane cells, donor2	12236-129G4	91.63	43.62	0.68	0.00	0.00	0.34	0.34	0.00
amniotic membrane cells, donor3	12237-129G5	87.20	48.61	1.18	0.00	0.29	0.88	0.88	0.29
amygdala - adult, donor10196	10167-103B5	35.57	15.42	0.00	0.00	0.00	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	48.87	18.45	0.41	0.81	1.01	0.00	0.20	0.41
amygdala, newborn, donor10223	10360-105E9	20.33	13.88	0.00	0.32	0.00	0.00	0.00	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	207.80	119.82	1.02	0.51	0.51	0.25	0.76	0.64
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	17.43	6.62	0.00	0.00	0.22	0.22	0.22	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	36.08	17.70	0.33	0.00	0.00	0.00	0.00	0.33
aorta, adult, pool1	10052-101G7	95.32	45.70	0.98	0.98	0.98	0.78	0.00	0.59
appendix, adult	10189-103D9	115.66	55.11	0.39	0.78	0.78	0.39	0.00	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	23.39	6.88	0.00	0.00	0.00	0.00	0.00	0.00
artery, adult	10190-103E1	51.63	12.23	0.00	0.00	0.00	0.00	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	43.32	12.75	0.14	0.14	0.00	0.00	0.00	0.00
b cell line:RPMI1788	10427-106D4	41.79	13.83	0.00	0.15	0.00	0.00	0.00	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	86.56	43.00	1.39	0.55	1.94	0.28	0.00	0.83
bile duct carcinoma cell line:HuCCT1	10432-106D9	99.43	43.46	0.50	0.20	0.50	0.40	0.30	0.10
bile duct carcinoma cell line:TFK-1	10496-107C1	81.68	23.43	0.33	0.33	0.00	0.17	0.00	0.50
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	35.79	21.25	0.56	0.00	0.00	0.00	0.00	0.00
bladder, adult, pool1	10011-101C2	104.30	37.81	0.98	0.43	0.00	0.33	0.22	0.00
blood, adult, pool1	10053-101G8	22.15	4.43	0.00	0.00	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	161.85	64.23	0.00	0.00	0.00	0.00	0.00	0.00
bone marrow, adult	10192-103E3	135.64	56.01	2.02	4.05	2.70	1.35	2.70	0.67
brain, adult, donor1	10084-102B3	16.40	11.28	1.03	0.00	0.00	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	41.54	18.49	0.22	0.22	0.78	0.22	0.22	0.00
brain, fetal, pool1	10085-102B4	10.69	5.34	0.00	0.00	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	39.31	20.48	0.33	0.66	0.66	0.33	0.00	0.99
breast carcinoma cell line:MDA-MB-453	10419-106C5	176.75	50.93	0.25	0.00	0.25	0.12	0.00	0.00
breast, adult, donor1	10080-102A8	45.46	27.78	1.26	0.00	0.00	0.00	0.63	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	41.16	23.63	0.64	0.38	1.40	0.25	0.38	0.51
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	53.50	22.57	0.62	0.93	1.24	0.31	0.62	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	19.34	4.37	0.69	0.23	0.00	0.00	0.23	0.23
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	30.99	15.49	0.24	0.48	0.00	0.00	0.00	0.00
carcinoid cell line:NCI-H1770	10703-109H1	21.16	13.63	0.00	0.00	0.00	0.00	0.00	0.47
carcinoid cell line:NCI-H727	10735-110B6	77.44	37.52	0.55	0.11	0.44	0.22	0.22	0.22
carcinoid cell line:SK-PN-DW	10719-109I8	32.32	24.72	0.32	0.95	1.27	0.32	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	38.86	17.57	1.33	0.80	0.53	0.00	0.27	0.00
caudate nucleus - adult, donor10196	10177-103C6	61.02	21.88	1.15	0.00	0.00	0.00	0.00	1.15
caudate nucleus, adult, donor10252	10164-103B2	39.32	16.40	0.50	0.84	0.50	0.33	0.50	0.33
caudate nucleus, adult, donor10258	10379-105H1	29.04	6.11	0.00	0.00	0.00	0.00	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	33.69	11.72	0.00	0.00	0.37	0.37	0.37	0.37
cerebellum - adult, donor10196	10173-103C2	55.35	26.22	0.00	0.00	0.00	0.00	0.00	2.91
cerebellum, adult, donor10252	10166-103B4	50.17	23.27	0.21	1.49	0.85	0.43	0.00	0.85
cerebellum, adult, pool1	10083-102B2	15.52	7.59	0.00	0.00	0.00	0.69	0.00	0.34
cerebellum, newborn, donor10223	10357-105E6	37.36	11.62	0.00	0.00	0.00	0.00	0.00	0.00
cerebral meninges, adult	10188-103D8	20.68	7.31	0.25	0.50	0.00	0.00	0.00	0.00
cerebrospinal fluid, donor2	10294-104G6	32.16	21.20	0.73	0.73	0.73	0.00	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	72.32	30.63	0.14	0.00	0.29	0.00	0.43	0.00
cervical cancer cell line:ME-180	10553-107I4	67.61	22.37	0.00	0.00	0.00	0.50	0.00	0.00
cervix, adult, pool1	10013-101C4	168.82	49.35	1.05	0.52	0.42	1.15	0.31	0.63
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	137.95	49.19	0.28	0.56	0.98	0.14	0.00	0.28
chondrosarcoma cell line:SW 1353	10700-109G7	116.26	88.83	0.00	0.00	0.00	0.00	1.31	0.00
choriocarcinoma cell line:BeWo	10423-106C9	111.35	34.18	0.50	0.00	0.87	0.50	0.25	0.50
choriocarcinoma cell line:SCH	10785-110H2	34.01	12.57	0.00	0.12	0.25	0.25	0.49	0.12
choriocarcinoma cell line:T3M-3	10618-108G6	42.93	16.13	0.24	0.24	0.00	0.47	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	168.67	56.70	0.28	0.57	0.85	0.28	0.28	0.57
chorionic membrane cells, donor2	12239-129G7	164.46	54.19	1.39	0.20	1.09	0.20	0.10	0.40
chorionic membrane cells, donor3	12240-129G8	186.82	86.82	4.95	2.75	4.95	1.65	1.10	2.20
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	17.17	6.06	0.00	1.01	0.00	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	49.95	22.86	0.38	0.19	0.00	0.19	0.00	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	38.01	10.98	0.42	0.63	0.00	0.00	0.21	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	20.29	9.76	0.26	0.26	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	26.12	6.53	0.00	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	24.03	8.14	0.00	0.61	0.20	0.20	0.20	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	31.80	8.24	0.00	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	90.18	18.24	0.00	0.00	0.52	0.00	0.00	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	25.14	10.74	0.91	0.23	1.14	0.00	0.00	0.46
clear cell carcinoma cell line:TEN	10636-108I6	104.28	38.34	1.91	0.17	0.17	0.35	0.17	0.17
colon carcinoma cell line:CACO-2	10513-107D9	553.15	118.25	1.46	0.92	0.73	0.73	0.37	0.92
colon carcinoma cell line:COLO-320	10420-106C6	171.80	58.91	0.76	0.00	0.76	1.14	0.00	0.00
colon, adult, donor1	10082-102B1	114.24	57.12	0.00	1.19	0.00	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	159.80	53.93	0.59	0.12	0.24	0.24	0.12	0.00
colon, fetal, donor1	10070-101I7	107.53	68.60	1.24	0.62	0.62	0.62	1.85	0.00
common myeloid progenitor CMP, donor1	12130-128D6	288.76	45.84	0.00	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	50.07	25.04	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	82.44	24.65	0.00	0.42	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	72.75	25.66	0.30	0.30	0.00	0.15	0.00	0.15
cord blood derived cell line:COBL-a untreated	10449-106F8	83.06	27.36	0.28	0.14	0.28	0.00	0.28	0.42
corpus callosum, adult, pool1	10042-101F6	127.04	76.29	0.55	0.44	1.00	0.55	0.22	0.33
cruciate ligament, donor2	10295-104G7	86.72	59.16	0.00	0.81	0.00	0.81	0.00	0.81
diaphragm, fetal, donor1	10069-101I6	72.23	38.52	2.41	1.61	0.00	0.00	1.61	0.80
diencephalon, adult	10193-103E4	36.00	20.16	0.96	0.48	0.24	0.00	0.00	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	14.24	4.13	0.46	0.23	0.23	0.00	0.00	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	69.24	25.64	0.00	0.00	0.00	0.00	0.00	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	62.59	13.00	0.48	0.24	0.00	0.72	0.24	0.00
ductus deferens, adult	10196-103E7	270.10	135.05	5.48	3.99	2.49	2.49	1.50	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	174.27	86.41	0.00	1.44	1.44	1.44	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	324.42	141.24	3.68	8.09	1.47	4.41	2.94	1.47
dura mater, adult, donor1	10041-101F5	237.03	81.02	0.58	0.74	0.41	0.66	0.17	0.17
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	42.64	7.55	0.22	0.22	0.00	0.00	0.00	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	77.67	14.76	0.00	0.00	0.14	0.00	0.14	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	41.31	16.03	0.00	0.00	0.00	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	34.51	9.69	0.30	0.00	0.30	0.30	0.00	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	37.36	13.28	0.93	0.31	0.00	0.00	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	47.28	32.84	0.00	0.00	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	90.17	16.42	0.34	0.00	0.00	0.00	0.00	0.67
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	67.78	17.58	0.00	0.54	0.36	0.00	0.54	0.18
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	94.40	33.61	1.93	1.77	1.29	0.96	1.29	0.64
epidermoid carcinoma cell line:A431	10426-106D3	176.30	57.80	0.67	0.33	0.44	0.00	0.22	0.44
epidermoid carcinoma cell line:Ca Ski	10431-106D8	122.85	40.91	0.22	0.44	0.33	0.11	0.33	0.00
epididymis, adult	10197-103E8	139.40	59.24	1.67	1.05	1.88	1.47	1.05	2.30
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	185.39	53.58	0.71	1.24	0.89	0.53	0.53	0.53
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	47.58	12.19	0.00	0.00	0.00	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	39.18	17.30	0.39	0.52	0.66	1.05	0.26	0.26
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	28.64	13.09	0.59	0.20	0.39	0.39	0.00	0.10
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	29.91	15.12	0.22	0.45	0.90	0.67	0.00	0.11
esophagus, adult, pool1	10015-101C6	84.94	26.97	0.42	0.96	0.11	0.21	0.21	0.32
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	67.38	10.39	0.13	0.13	0.13	0.00	0.00	0.13
eye - muscle inferior rectus, donor1	10272-104E2	72.44	26.56	0.00	2.41	0.00	2.41	2.41	2.41
eye - muscle lateral, donor2	10298-104H1	61.02	35.77	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	49.11	32.74	0.00	1.49	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	57.32	35.54	1.15	0.00	0.00	0.00	1.15	0.00
eye - vitreous humor, donor1	10268-104D7	51.01	46.64	1.46	1.46	0.00	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	71.19	43.98	0.76	1.53	1.78	2.03	1.78	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	44.37	18.08	0.26	0.13	0.26	0.13	0.00	0.26
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	53.89	22.79	0.24	0.24	0.00	0.24	0.00	0.24
frontal lobe, adult, pool1	10040-101F4	38.75	18.58	0.38	0.19	0.09	0.09	0.00	0.00
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	164.84	37.23	0.60	0.60	0.60	0.00	0.90	1.50
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	178.21	63.18	0.55	0.27	0.46	0.00	0.00	0.09
gall bladder, adult	10198-103E9	195.32	95.12	2.41	1.45	1.69	1.45	1.21	0.72
gamma delta positive T cells, donor1	11937-126A2	47.78	11.81	0.00	0.54	0.00	0.00	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	56.40	19.80	0.00	0.00	0.00	0.37	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	39.08	12.88	0.63	0.00	0.42	0.42	0.00	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	61.70	19.15	0.39	0.97	0.19	0.39	0.19	0.00
gastric cancer cell line:AZ521	10549-107H9	211.34	64.27	0.66	0.33	0.66	0.33	0.16	0.00
gastric cancer cell line:GSS	10560-108A2	54.00	14.64	0.00	0.00	0.00	0.00	0.92	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	30.84	10.97	0.69	0.23	0.23	0.46	0.23	0.00
giant cell carcinoma cell line:LU65	10487-107B1	27.88	6.20	0.23	0.00	0.34	0.11	0.23	0.23
giant cell carcinoma cell line:Lu99B	10433-106E1	87.75	19.59	0.14	0.14	0.28	0.14	0.00	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	26.69	11.97	0.00	0.00	0.25	0.00	0.50	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	117.37	42.01	0.21	0.00	0.21	0.21	0.21	0.21
glioblastoma cell line:A172, tech_rep2	10444-106F3	126.68	48.59	0.00	0.98	0.42	0.14	0.42	0.14
glioblastoma cell line:T98G	10485-107A8	174.28	62.80	0.44	0.33	0.33	0.33	0.22	0.88
glioma cell line:GI-1	10413-106B8	144.68	57.40	0.59	0.00	0.59	0.59	0.29	0.00
globus pallidus - adult, donor10196	10175-103C4	54.67	56.13	1.46	0.73	0.73	0.00	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	89.83	61.27	0.98	0.73	1.46	1.22	0.73	0.24
globus pallidus, adult, donor10258	10367-105F7	41.08	24.65	0.00	0.00	0.00	0.00	0.00	1.37
globus pallidus, newborn, donor10223	10364-105F4	65.02	33.04	1.07	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	234.93	85.65	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	21.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	15.68	10.45	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	80.64	39.04	1.28	1.28	0.32	0.32	0.00	0.00
hIPS +CCl2, biol_rep1	14383-156B9	87.23	28.01	0.00	0.00	0.00	0.00	0.00	0.46
hIPS +CCl2, biol_rep2	14384-156C1	90.54	29.72	0.46	0.00	0.46	0.00	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	78.58	23.83	0.00	0.00	0.00	0.00	1.29	0.00
hIPS, biol_rep1	14380-156B6	91.99	40.24	0.00	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	65.84	24.69	0.00	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep3	14382-156B8	43.04	12.14	1.10	0.00	0.00	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	11.49	1.44	0.00	0.00	0.00	0.00	0.00	0.00
heart - mitral valve, adult	10205-103F7	99.26	42.15	1.20	0.90	0.30	0.00	0.30	0.60
heart - pulmonic valve, adult	10206-103F8	89.16	32.68	1.83	0.52	0.26	0.26	0.26	0.52
heart - tricuspid valve, adult	10207-103F9	169.03	65.78	0.00	0.83	1.67	0.83	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	34.89	15.10	0.61	0.61	1.02	0.61	0.41	0.82
heart, adult, diseased, donor1	10051-101G6	28.53	10.22	0.43	0.85	0.43	0.43	0.43	0.85
heart, adult, pool1	10016-101C7	71.06	25.30	0.00	0.00	0.00	0.00	0.00	0.00
heart, fetal, pool1	10046-101G1	96.31	30.50	0.10	0.21	0.10	0.31	0.00	0.00
hepatic mesenchymal tumor cell line:LI90	10778-110G4	133.90	89.16	0.31	1.23	0.93	0.62	0.31	0.93
hepatoblastoma cell line:HuH-6	10633-108I3	185.51	74.92	0.00	0.00	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	430.60	148.84	5.64	3.54	7.29	6.74	1.55	3.54
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	416.56	143.83	6.19	4.37	8.37	7.65	3.64	3.40
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	505.47	159.06	5.86	3.23	6.37	6.47	1.92	2.93
hepatoma cell line:Li-7	10484-107A7	96.65	33.81	0.33	0.22	0.56	0.11	0.00	0.33
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	7.94	3.12	0.00	0.00	0.10	0.00	0.00	0.20
hippocampus - adult, donor10196	10169-103B7	35.01	14.19	0.00	0.95	0.00	0.00	0.95	0.00
hippocampus, adult, donor10252	10153-102I9	49.39	27.96	1.02	1.02	1.22	0.82	0.00	0.20
hippocampus, adult, donor10258	10374-105G5	24.40	9.46	0.00	0.00	0.00	0.00	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	25.38	17.27	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	117.80	28.08	1.83	0.61	1.22	1.22	1.22	1.22
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	75.99	22.78	0.59	1.77	0.39	0.79	0.39	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	100.80	24.37	2.54	0.25	0.25	0.25	0.00	0.51
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	20.86	5.07	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	19.88	5.16	1.29	1.55	0.26	0.00	0.00	0.77
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	22.40	6.07	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	20.44	9.05	0.00	0.00	0.00	0.29	0.29	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	22.84	6.03	1.29	0.22	0.00	0.22	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	28.78	7.09	0.00	0.00	0.42	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	20.13	5.68	0.24	0.24	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	29.89	8.36	0.16	0.32	0.32	0.00	0.16	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	34.34	8.08	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	62.28	18.15	0.63	0.47	0.47	0.31	0.31	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	72.71	15.72	0.00	0.98	1.97	1.47	0.98	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	72.44	21.82	0.87	1.75	1.75	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	32.07	6.87	0.38	0.38	0.38	0.00	0.19	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	25.29	5.67	0.00	0.44	0.00	0.00	0.44	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	27.99	8.00	0.00	0.00	0.50	0.00	0.00	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	17.14	3.77	0.19	0.38	0.19	0.00	0.00	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	17.73	6.37	0.91	0.00	0.45	0.45	0.45	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	16.91	5.95	0.31	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	25.80	8.98	0.33	0.33	0.33	0.16	0.16	0.33
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	23.52	5.52	0.29	0.87	0.00	0.29	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	25.41	8.67	0.30	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	75.01	22.35	1.29	0.92	0.92	0.74	0.18	0.18
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	73.32	24.53	0.29	0.57	0.29	0.00	0.29	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	107.39	32.26	0.82	0.82	0.41	0.82	0.00	1.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	39.08	9.15	2.11	0.70	0.35	1.06	0.35	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	41.18	8.87	0.32	0.32	0.00	0.00	0.00	0.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	40.25	9.38	0.00	0.30	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	34.13	11.38	0.52	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	36.53	8.63	0.00	0.66	0.00	0.00	0.00	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	37.45	13.85	0.26	0.26	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	40.39	16.87	0.51	0.26	0.77	0.26	0.51	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	31.80	13.63	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	36.29	14.79	0.67	0.34	0.67	0.00	0.00	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	70.52	22.22	0.24	1.69	1.21	0.48	0.72	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	83.34	30.30	0.89	1.78	0.00	0.00	0.45	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	74.15	27.32	1.95	0.49	0.49	0.00	0.49	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	37.59	12.22	0.00	0.92	0.31	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	81.33	39.04	13.01	0.00	0.00	0.00	3.25	6.51
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	39.38	11.25	0.00	0.00	0.00	0.66	1.65	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	25.72	6.02	0.55	0.00	0.00	0.00	0.00	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	29.67	6.15	0.00	0.00	0.00	0.00	0.36	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	21.00	6.05	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	26.25	3.58	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	28.71	5.96	0.14	0.00	0.00	0.00	0.00	0.27
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	17.78	3.50	0.00	0.00	0.00	0.00	0.00	0.00
immature langerhans cells, donor1	11904-125F5	61.99	25.67	0.00	0.00	0.24	0.00	0.00	0.24
immature langerhans cells, donor2	11905-125F6	37.23	16.63	0.00	0.00	0.00	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	36.62	14.76	0.09	0.09	0.00	0.00	0.00	0.00
keratoacanthoma cell line:HKA-1	10791-110H8	30.89	12.68	0.00	0.33	0.33	0.33	0.65	0.33
kidney, adult, pool1	10017-101C8	164.11	57.27	0.80	0.30	0.70	0.50	0.50	0.50
kidney, fetal, pool1	10045-101F9	146.85	44.85	0.21	0.50	0.14	0.07	0.14	0.21
large cell lung carcinoma cell line:IA-LM	10509-107D5	73.42	22.72	0.00	0.14	0.28	0.00	0.00	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	29.03	24.61	0.69	0.69	0.28	0.00	0.14	0.55
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	31.75	20.92	0.00	0.18	0.18	0.00	0.18	0.00
left atrium, adult, donor1	10079-102A7	38.68	17.44	0.00	0.00	0.54	0.00	0.00	0.00
left ventricle, adult, donor1	10078-102A6	28.32	14.16	0.51	0.00	0.00	1.01	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	40.77	15.60	0.00	0.00	0.27	0.00	0.27	0.27
leiomyoma cell line:10964C	10569-108B2	85.86	29.10	1.44	2.87	1.44	2.16	0.72	0.72
leiomyoma cell line:15242A	10570-108B3	98.37	41.85	1.63	1.63	1.09	1.09	2.72	0.54
leiomyoma cell line:15425	10571-108B4	108.54	37.88	2.43	1.70	3.16	1.70	0.97	1.46
leiomyosarcoma cell line:Hs 5.T	10722-110A2	101.59	38.10	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	41.82	24.05	0.00	0.00	0.00	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	114.16	32.35	0.35	0.35	1.18	1.06	0.35	0.12
liposarcoma cell line:KMLS-1	10782-110G8	161.05	87.01	1.87	0.94	0.78	0.78	1.72	0.47
liposarcoma cell line:SW 872	10726-110A6	97.23	43.86	0.37	1.10	1.10	0.24	0.12	0.49
liver, adult, pool1	10018-101C9	407.42	140.18	1.46	0.65	1.30	1.62	0.32	0.49
liver, fetal, pool1	10086-102B5	83.72	40.45	2.82	0.00	0.00	0.00	0.94	0.00
locus coeruleus - adult, donor10196	10182-103D2	60.37	32.96	0.29	0.44	0.29	0.15	0.00	0.15
locus coeruleus, adult, donor10252	10165-103B3	63.85	34.70	1.29	1.48	0.37	0.55	0.00	0.37
locus coeruleus, adult, donor10258	10375-105G6	35.83	16.93	0.28	0.28	0.56	0.28	0.00	0.28
locus coeruleus, newborn, donor10223	10362-105F2	60.57	16.82	0.84	0.00	0.42	0.42	0.00	0.00
lung adenocarcinoma cell line:A549	10499-107C4	106.70	61.17	0.42	0.42	0.14	0.28	0.00	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	142.71	53.08	0.00	0.00	0.00	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	62.61	27.02	0.13	0.66	0.13	0.26	0.00	0.26
lung, adult, pool1	10019-101D1	132.18	37.56	0.59	0.24	0.35	0.12	0.12	0.24
lung, fetal, donor1	10068-101I5	266.00	77.35	0.57	0.00	0.57	0.00	0.86	0.00
lung, right lower lobe, adult, donor1	10075-102A3	82.48	38.49	1.83	0.00	1.37	0.92	0.00	0.46
lymph node, adult, donor1	10077-102A5	49.23	19.41	0.47	0.00	0.47	0.47	0.00	1.42
lymphangiectasia cell line:DS-1	10727-110A7	86.79	33.10	0.44	0.00	1.32	0.00	0.00	0.88
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	17.36	7.85	0.15	0.15	0.00	0.00	0.00	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	135.07	28.03	0.00	0.00	0.00	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	136.30	53.28	0.00	0.44	0.00	0.00	0.00	0.00
mature adipocyte, donor2	12232-129F9	98.78	37.98	0.00	0.00	0.00	0.21	0.21	0.21
mature adipocyte, donor3	12233-129G1	93.64	40.54	0.95	0.00	0.24	0.00	0.00	0.00
mature adipocyte, donor4	12234-129G2	71.60	32.11	0.53	0.26	0.00	0.00	0.00	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	160.35	57.66	0.48	0.00	0.00	0.00	0.24	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	20.30	19.18	2.26	0.00	0.00	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	48.00	22.25	0.18	0.74	0.92	0.92	0.55	0.18
medial frontal gyrus, adult, donor10258	10368-105F8	15.88	11.44	0.00	0.00	0.00	0.00	0.00	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	37.96	13.65	1.28	0.43	0.00	0.00	0.43	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	33.75	16.54	0.51	1.35	0.51	1.01	0.00	0.68
medial temporal gyrus, adult, donor10252	10156-103A3	52.42	33.53	0.85	0.85	0.64	0.21	0.42	0.42
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	11.56	17.34	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	57.41	43.06	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	25.84	11.84	0.36	0.00	0.00	0.00	0.00	0.00
medulla oblongata - adult, donor10196	10174-103C3	80.47	33.75	0.00	0.00	0.00	0.00	0.65	0.00
medulla oblongata, adult, donor10252	10155-103A2	78.18	45.36	1.24	1.55	1.08	0.62	0.15	0.93
medulla oblongata, adult, pool1	10038-101F2	90.77	39.18	0.16	0.49	0.08	0.08	0.08	0.08
medulla oblongata, newborn, donor10223	10361-105F1	53.12	25.34	0.69	0.00	0.00	0.00	0.35	0.00
medulloblastoma cell line:D283 Med	10838-111E1	49.82	25.68	0.89	1.33	0.22	0.00	0.44	0.66
medulloblastoma cell line:ONS-76	10759-110E3	142.57	59.42	0.61	1.10	0.37	0.12	0.00	0.24
melanoma cell line:COLO 679	10514-107E1	56.20	16.39	0.57	0.14	0.00	0.00	0.00	0.00
melanoma cell line:G-361	10465-106H6	101.80	38.55	1.09	1.09	3.26	0.00	0.00	0.27
meningioma cell line:HKBMM	10691-109F7	53.37	22.79	1.27	1.45	0.36	0.72	0.90	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	10.57	6.17	0.00	0.00	0.88	0.00	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	11.41	2.59	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	145.92	82.09	1.99	0.92	1.23	1.23	1.23	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	113.79	50.54	0.91	0.55	0.36	1.64	0.91	0.91
mesenchymal precursor cell - adipose, donor3	11749-123G3	90.69	38.93	0.00	0.41	0.83	2.07	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	109.57	45.65	2.11	0.84	0.56	0.84	0.42	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	102.25	40.82	2.12	0.96	1.16	2.12	0.39	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	135.35	53.44	0.69	0.69	2.08	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	78.44	34.84	1.03	0.69	0.51	1.89	0.17	0.34
mesenchymal precursor cell - cardiac, donor2	11753-123G7	106.27	41.98	0.81	0.92	0.58	0.69	0.23	0.23
mesenchymal precursor cell - cardiac, donor3	11754-123G8	98.68	42.58	1.33	0.80	0.66	0.80	0.80	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	83.86	41.73	0.95	1.22	0.54	1.22	0.54	0.54
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	119.50	55.62	1.71	0.71	0.71	1.56	0.28	0.43
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	83.99	32.94	0.66	0.99	0.66	0.33	0.33	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	96.17	43.86	1.38	0.28	0.55	1.66	0.28	0.42
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	168.96	61.09	2.09	1.05	1.75	0.70	0.35	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	89.63	48.80	0.41	0.41	0.20	1.02	0.20	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	125.45	45.65	0.72	0.72	0.36	0.36	0.72	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	72.62	34.03	0.41	1.03	0.52	1.03	0.52	0.21
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	132.46	54.95	2.51	2.05	0.23	0.46	0.68	1.14
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	110.34	45.31	2.10	0.84	0.42	0.42	0.84	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	74.57	36.16	1.20	0.75	0.45	0.75	0.15	0.30
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	86.22	35.71	0.96	0.61	1.05	1.05	1.23	0.53
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	78.79	36.08	1.10	1.47	0.00	0.00	0.00	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	144.80	67.53	2.00	0.86	2.00	0.57	0.29	0.57
mesenchymal stem cell line:Hu5/E18	10568-108B1	129.67	44.21	1.68	3.37	2.11	0.42	0.42	1.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	111.43	51.15	0.46	0.46	1.37	0.00	0.46	1.37
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	143.75	54.23	1.53	0.00	1.79	0.51	1.28	0.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	136.64	55.75	1.05	0.26	1.57	0.00	0.26	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	143.26	62.54	2.77	2.16	0.92	0.62	0.31	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	139.33	54.60	2.12	0.24	0.94	0.47	0.71	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	135.38	49.08	1.69	0.34	1.02	0.34	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	146.19	56.98	1.57	1.18	0.79	0.79	0.79	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	130.67	51.44	1.39	0.46	3.24	0.46	0.46	0.93
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	241.52	0.00	0.00	0.00	0.00	0.00	0.00	48.30
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	177.95	70.95	2.88	0.87	1.15	1.15	1.44	0.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	163.09	58.23	1.12	0.45	1.34	0.67	0.22	0.45
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	166.32	60.09	1.20	0.72	1.44	0.48	0.72	0.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	193.60	80.67	1.47	1.47	0.00	1.47	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	136.95	53.03	1.68	0.34	0.67	0.00	1.01	1.01
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	167.44	58.95	1.64	0.82	0.41	0.41	0.82	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	159.37	57.56	0.43	0.86	0.86	1.29	1.29	0.86
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	155.86	65.63	2.73	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	108.46	61.98	0.00	5.16	0.00	5.16	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	129.59	54.24	2.92	0.00	0.32	0.00	0.00	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	122.22	34.92	4.36	0.00	0.00	0.00	1.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	108.22	51.71	3.73	0.53	0.00	0.00	1.07	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	116.12	53.97	1.64	0.00	0.82	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	125.17	53.25	3.11	0.39	0.39	0.00	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	119.63	33.58	2.10	0.00	2.10	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	138.09	50.67	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	95.34	42.90	4.77	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	102.58	53.37	1.19	0.00	0.59	0.00	1.19	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	129.16	52.39	2.44	2.44	1.22	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	108.21	54.10	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	113.38	47.50	1.27	1.27	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	67.60	17.94	1.03	0.00	1.03	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	79.52	21.49	2.15	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	43.91	3.99	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	55.10	17.22	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	55.82	28.12	0.00	0.81	0.00	0.00	0.41	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	53.23	19.86	0.00	0.00	0.79	0.00	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	48.34	18.86	0.00	0.59	1.77	0.59	0.59	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	42.70	19.33	0.00	0.31	1.25	0.00	0.00	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	50.79	17.38	0.00	0.00	0.00	0.00	2.67	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	46.12	18.92	1.18	1.18	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	33.38	15.41	0.00	2.57	0.00	0.00	0.00	5.14
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	41.99	29.60	0.00	0.69	0.00	0.00	0.00	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	52.94	21.77	0.49	0.00	0.99	0.49	0.99	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	49.35	19.07	1.12	0.00	2.24	1.12	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	41.34	9.54	0.00	0.00	0.64	0.64	0.64	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	57.22	16.52	0.40	0.81	0.40	0.40	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	54.51	28.35	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	41.81	16.47	0.00	0.00	3.80	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	124.41	44.91	1.82	0.61	0.61	0.00	0.00	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	189.80	31.63	0.00	4.52	4.52	0.00	0.00	4.52
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	112.84	48.60	0.82	4.12	1.65	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	56.55	21.63	0.00	0.00	0.79	0.20	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	53.87	24.99	0.00	1.30	0.00	0.00	0.32	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	62.14	20.37	1.02	2.04	1.02	0.00	2.04	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	127.66	47.20	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	156.16	47.96	0.00	0.00	0.47	0.00	0.24	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	164.26	50.50	1.39	0.23	0.46	0.46	0.00	0.46
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	72.65	34.19	4.27	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	107.17	35.24	1.34	0.21	0.31	0.10	0.31	0.31
mesothelioma cell line:Mero-25	10850-111F4	37.22	13.62	0.23	0.00	0.45	0.00	0.23	0.23
mesothelioma cell line:Mero-41	10851-111F5	123.22	47.92	0.98	0.73	0.98	0.73	0.24	0.49
mesothelioma cell line:Mero-48a	10852-111F6	95.88	46.50	0.44	1.11	0.66	0.00	0.22	0.22
mesothelioma cell line:Mero-82	10853-111F7	92.51	39.95	0.79	1.84	0.79	0.53	0.79	0.53
mesothelioma cell line:Mero-83	10854-111F8	103.83	47.32	0.85	1.02	1.36	0.68	0.17	0.51
mesothelioma cell line:Mero-84	10855-111F9	103.89	39.69	0.76	1.01	0.25	0.51	1.01	0.51
mesothelioma cell line:Mero-95	10856-111G1	102.49	46.58	2.07	0.83	1.04	0.83	0.83	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	197.29	78.68	1.33	1.66	1.49	1.33	0.83	0.99
mesothelioma cell line:NCI-H226	10846-111E9	75.11	34.03	0.36	0.72	0.90	0.72	0.00	0.36
mesothelioma cell line:NCI-H2452	10848-111F2	95.83	35.19	1.02	0.85	1.02	0.17	1.37	0.17
mesothelioma cell line:NCI-H28	10845-111E8	31.04	8.14	0.51	0.51	0.76	0.51	0.25	0.51
mesothelioma cell line:No36	10857-111G2	44.36	26.42	0.00	0.00	0.00	0.00	0.00	0.33
mesothelioma cell line:ONE58	10858-111G3	91.85	30.08	0.54	0.27	0.00	0.00	0.00	0.27
migratory langerhans cells, donor1	11901-125F2	73.31	20.34	0.58	1.15	0.19	0.00	0.19	0.19
migratory langerhans cells, donor2	11902-125F3	78.76	21.98	0.73	0.49	0.12	0.00	0.24	0.12
migratory langerhans cells, donor3	11903-125F4	91.00	27.28	0.18	0.18	0.36	0.00	0.18	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	111.98	47.01	2.61	2.94	3.59	2.29	1.63	2.29
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	40.90	16.74	1.06	0.64	0.42	0.00	0.64	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	97.44	61.74	0.00	0.00	0.23	0.00	0.00	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	25.88	5.71	0.19	0.19	0.00	0.00	0.19	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	48.42	14.78	0.74	0.00	0.74	0.00	0.37	0.37
myeloma cell line:PCM6	10474-106I6	16.60	5.93	0.00	0.00	0.00	0.00	0.20	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	137.98	67.47	0.51	0.51	0.00	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	160.64	76.69	1.57	0.98	0.98	0.20	0.59	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	41.45	10.03	0.11	0.11	0.11	0.22	0.00	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	43.09	10.22	0.07	0.15	0.29	0.07	0.15	0.15
nasal epithelial cells, donor2	12227-129F4	155.11	65.69	0.55	0.00	0.00	0.00	0.00	0.55
neuroblastoma cell line:CHP-134	10508-107D4	8.28	2.76	0.00	0.00	0.00	0.00	0.00	0.00
neuroblastoma cell line:NB-1	10539-107G8	66.23	19.27	0.00	0.19	0.00	0.00	0.00	0.37
neuroblastoma cell line:NBsusSR	10607-108F4	57.36	13.08	0.63	0.42	0.21	0.21	0.21	0.42
neuroblastoma cell line:NH-12	10555-107I6	12.30	5.40	0.00	0.19	0.00	0.19	0.00	0.37
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	38.43	15.18	0.71	0.47	0.00	0.47	1.19	0.47
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	48.94	25.97	1.11	1.58	0.79	0.48	0.32	0.16
neuroectodermal tumor cell line:TASK1	10774-110F9	11.27	6.04	0.20	0.60	0.20	0.00	0.00	0.40
neuroepithelioma cell line:SK-N-MC	10728-110A8	26.70	10.81	0.00	0.00	0.64	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	129.89	68.94	0.80	1.86	0.53	0.53	0.27	0.53
neutrophil PMN, donor1	12133-128D9	119.00	14.87	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	13.28	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	9.47	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	117.88	30.10	0.85	0.17	0.34	0.17	0.00	0.17
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	4.00	0.80	0.00	0.00	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	114.14	55.79	1.60	0.96	0.96	0.64	0.64	0.64
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	152.67	77.25	2.63	2.63	2.63	2.36	2.36	2.10
nucleus accumbens, adult, pool1	10037-101F1	39.00	20.81	0.09	0.00	0.09	0.00	0.00	0.00
occipital cortex - adult, donor10196	10172-103C1	47.39	20.60	2.06	0.00	0.00	0.00	0.00	2.06
occipital cortex, adult, donor10252	10163-103B1	60.65	34.08	0.81	0.81	0.54	0.54	0.54	0.81
occipital cortex, newborn, donor10223	10355-105E4	34.57	14.19	0.36	0.36	0.00	0.36	0.36	0.00
occipital lobe, adult, donor1	10076-102A4	29.65	18.11	0.00	0.00	0.00	0.00	0.26	0.00
occipital lobe, fetal, donor1	10073-102A1	10.73	2.57	0.00	0.00	0.00	0.00	0.43	0.00
occipital pole, adult, pool1	10036-101E9	30.98	16.48	0.24	0.00	0.08	0.00	0.00	0.08
olfactory region, adult	10195-103E6	32.86	15.86	0.38	0.76	0.57	0.38	0.00	0.38
optic nerve, donor1	10277-104E7	92.05	98.05	0.00	0.00	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	87.94	33.72	0.46	0.23	0.23	0.11	0.34	0.11
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	102.90	26.93	0.14	0.00	0.14	0.14	0.14	0.55
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	71.62	18.63	2.54	1.02	1.19	0.68	0.51	1.19
oral squamous cell carcinoma cell line:SAS	10544-107H4	30.61	11.44	0.23	0.35	0.58	0.23	0.23	0.23
osteoclastoma cell line:Hs 706.T	10704-109H2	151.69	89.95	0.29	0.59	0.29	0.59	0.00	0.88
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	123.33	57.93	0.00	0.00	0.00	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	381.71	91.19	0.85	1.06	1.06	0.21	0.21	0.21
ovary, adult, pool1	10020-101D2	141.16	41.93	0.44	0.44	0.26	0.79	0.09	0.17
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	136.39	99.54	1.28	1.10	0.55	0.92	0.37	1.65
pancreas, adult, donor1	10049-101G4	529.58	385.66	8.47	5.64	4.70	11.29	3.76	4.70
pancreatic carcinoma cell line:NOR-P1	10698-109G5	44.73	26.28	0.00	0.00	0.28	0.28	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	124.02	51.96	1.53	2.90	2.90	1.70	1.70	1.02
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	91.57	30.47	0.83	0.33	0.50	0.00	0.00	0.00
paracentral gyrus, adult, pool1	10035-101E8	36.43	17.85	0.27	0.18	0.18	0.46	0.00	0.18
parietal cortex, adult, donor10258	10373-105G4	109.37	60.92	0.00	0.00	0.00	0.00	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	32.92	20.69	0.94	0.00	0.00	0.00	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	43.33	20.52	0.57	0.29	0.86	0.29	0.00	0.57
parietal lobe, adult, pool1	10034-101E7	34.45	16.30	0.09	0.00	0.00	0.00	0.00	0.00
parietal lobe, fetal, donor1	10072-101I9	13.58	2.91	0.97	0.00	0.00	0.00	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	28.41	14.21	0.37	0.00	0.00	0.37	0.00	0.75
parotid gland, adult	10199-103F1	516.76	299.08	4.93	4.93	8.63	4.32	2.47	3.70
penis, adult	10200-103F2	83.25	27.93	0.00	2.69	0.00	0.00	0.54	1.07
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	31.80	9.85	0.74	0.56	0.19	0.37	0.00	0.56
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	31.32	12.38	0.15	0.15	0.29	0.44	0.15	0.44
pineal gland - adult, donor10196	10179-103C8	55.47	34.83	0.65	0.00	0.00	0.00	0.00	0.65
pineal gland, adult, donor10252	10160-103A7	59.22	14.21	0.59	0.59	0.00	0.00	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	25.71	10.66	0.00	0.00	0.00	0.00	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	153.79	45.53	4.05	0.00	2.02	1.01	1.01	0.00
pituitary gland, adult, donor10252	10162-103A9	243.91	54.72	2.61	1.56	1.04	0.00	0.52	0.00
pituitary gland, adult, donor10258	10378-105G9	112.36	35.75	0.00	0.00	0.85	0.00	0.00	0.00
placenta, adult, pool1	10021-101D3	289.72	91.27	0.86	0.32	1.40	1.18	0.86	0.97
plasma cell leukemia cell line:ARH-77	10840-111E3	29.93	11.65	0.00	0.13	0.53	0.13	0.00	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	104.59	61.79	0.78	0.16	0.16	0.16	0.16	0.00
pons, adult, pool1	10033-101E6	57.75	30.12	0.09	0.09	0.26	0.00	0.00	0.00
postcentral gyrus, adult, pool1	10032-101E5	34.00	17.00	0.26	0.00	0.09	0.17	0.00	0.09
promyelocytes/myelocytes PMC, donor1	12132-128D8	328.35	135.94	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	27.54	5.51	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	35.21	11.74	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	42.97	9.91	0.44	0.00	0.29	0.15	0.00	0.00
prostate cancer cell line:PC-3	10439-106E7	125.24	42.83	0.54	0.73	0.73	0.18	0.54	0.36
prostate, adult, pool1	10022-101D4	122.25	40.99	0.27	0.36	0.09	0.36	0.00	0.18
putamen, adult, donor10196	10176-103C5	33.99	16.52	0.71	0.71	0.94	0.47	0.24	0.24
putamen, adult, donor10252	10152-102I8	43.14	19.61	0.00	0.00	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	40.43	18.58	0.00	0.00	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	26.34	13.53	0.00	0.48	0.00	0.24	0.24	0.00
putamen, newborn, donor10223	10365-105F5	30.74	13.49	0.75	0.75	0.00	0.00	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	243.80	71.28	0.58	0.00	0.29	0.29	0.29	0.00
rectum, fetal, donor1	10067-101I4	161.36	104.32	5.56	1.39	0.00	2.78	1.39	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	160.91	55.12	0.85	0.85	0.64	0.00	0.00	0.64
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	32.72	21.12	0.00	0.00	0.00	0.00	0.41	0.00
retina, adult, pool1	10030-101E3	117.89	36.28	0.50	0.70	0.40	0.30	0.40	0.00
retinoblastoma cell line:Y79	10475-106I7	17.41	6.24	0.00	0.26	0.00	0.00	0.26	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	27.42	10.82	0.25	0.25	0.12	0.12	0.00	0.37
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	77.33	20.81	0.00	0.00	0.00	0.00	0.00	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	249.33	125.05	0.00	0.00	0.76	0.00	1.52	0.76
salivary acinar cells, donor1	11771-123I7	60.21	22.98	0.81	0.49	0.49	0.81	0.16	0.32
salivary acinar cells, donor2	11772-123I8	37.86	15.42	0.28	0.28	0.28	0.14	0.00	0.28
salivary acinar cells, donor3	11773-123I9	48.99	29.79	0.00	0.66	0.00	0.00	0.66	0.00
salivary gland, adult, pool1	10093-102C3	430.11	165.87	0.00	4.00	1.14	1.14	1.14	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	28.83	8.52	0.25	0.08	0.00	0.00	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	23.51	7.99	0.12	0.00	0.12	0.00	0.00	0.00
seminal vesicle, adult	10201-103F3	308.45	152.90	3.17	2.65	2.65	1.06	5.29	3.17
serous adenocarcinoma cell line:JHOS-2	10639-108I9	59.03	19.92	0.00	0.00	0.00	0.49	0.49	0.73
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	74.23	25.92	0.50	0.00	0.25	0.25	0.00	0.50
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	159.56	53.19	0.00	2.01	0.00	2.01	1.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	163.60	56.68	1.61	1.61	1.07	1.07	1.07	0.81
signet ring carcinoma cell line:Kato III	10436-106E4	104.34	40.90	0.44	0.11	0.22	0.11	0.00	0.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	161.93	54.45	0.39	1.03	0.77	0.13	0.52	0.13
skeletal muscle - soleus muscle, donor1	10282-104F3	24.83	10.64	0.00	0.71	0.00	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	48.45	15.23	0.12	0.00	0.00	0.00	0.00	0.00
skeletal muscle, fetal, donor1	10066-101I3	88.44	64.32	2.01	1.01	0.00	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	47.50	6.79	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	188.74	100.37	5.05	3.79	3.16	0.63	1.89	1.26
small cell cervical cancer cell line:HCSC-1	10800-110I8	14.34	7.67	0.33	0.00	0.00	0.00	0.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	29.94	7.88	1.58	0.32	0.00	0.00	0.63	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	24.86	6.17	0.39	0.00	0.19	0.00	0.39	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	40.05	9.40	0.00	0.00	0.00	0.00	0.00	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	30.24	23.16	0.80	0.32	0.32	0.00	0.32	0.16
small cell lung carcinoma cell line:WA-hT	10562-108A4	51.86	15.91	0.22	0.22	0.00	0.22	0.00	0.44
small intestine, adult, pool1	10024-101D6	245.34	81.94	0.60	0.36	0.96	0.12	0.12	0.48
small intestine, fetal, donor1	10064-101I1	149.63	60.69	3.44	2.21	2.46	1.97	1.47	0.98
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	424.17	149.25	10.26	4.62	4.62	2.56	3.08	6.15
smooth muscle, adult, pool1	10048-101G3	62.80	28.43	1.03	0.26	0.78	0.52	0.00	0.00
somatostatinoma cell line:QGP-1	10781-110G7	77.46	49.85	0.00	0.27	0.00	0.00	0.27	0.27
spinal cord - adult, donor10196	10181-103D1	74.10	42.67	2.29	1.15	0.69	0.00	0.92	0.23
spinal cord, adult, donor10252	10159-103A6	93.05	39.03	1.18	0.00	0.00	0.00	0.39	0.00
spinal cord, adult, donor10258	10369-105F9	46.35	24.90	0.00	1.38	0.00	0.00	0.69	0.00
spinal cord, fetal, donor1	10056-101H2	101.23	43.30	1.83	1.22	4.88	0.61	1.22	0.00
spinal cord, newborn, donor10223	10359-105E8	68.88	28.01	0.92	0.00	0.00	0.00	1.84	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	161.45	106.34	0.90	1.05	0.60	0.75	0.45	0.45
spleen, adult, pool1	10025-101D7	126.54	31.94	0.33	0.44	0.33	0.33	0.00	0.11
spleen, fetal, pool1	10044-101F8	141.27	40.12	0.48	0.32	0.16	0.32	0.08	0.08
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	26.71	7.87	0.10	0.21	0.10	0.10	0.00	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	135.76	40.06	0.57	0.00	0.57	0.19	0.19	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	48.57	16.07	2.80	0.35	2.45	1.05	1.05	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	152.46	75.06	0.78	0.78	1.17	1.56	0.39	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	92.86	26.56	0.56	0.00	0.23	0.11	0.11	0.34
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	55.92	19.06	0.00	0.00	0.00	0.00	0.85	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	36.38	13.12	0.00	0.00	0.00	0.00	0.00	0.00
stomach, fetal, donor1	10062-101H8	147.38	87.57	2.14	0.00	0.00	1.07	0.00	1.07
submaxillary gland, adult	10202-103F4	307.06	153.81	7.41	3.42	3.42	0.57	2.28	3.42
substantia nigra - adult, donor10196	10178-103C7	162.82	162.82	0.00	54.27	0.00	0.00	0.00	54.27
substantia nigra, adult, donor10252	10158-103A5	74.98	56.29	1.25	0.42	1.87	0.42	0.42	0.62
substantia nigra, adult, donor10258	10371-105G2	29.48	16.03	0.52	0.00	0.00	0.00	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	85.50	31.80	0.00	0.00	0.00	0.00	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	48.37	9.17	0.46	0.00	0.23	0.00	0.23	0.23
temporal lobe, adult, pool1	10031-101E4	34.33	20.18	0.17	0.17	0.08	0.17	0.08	0.25
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	11.40	2.85	0.00	0.00	0.00	0.00	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	17.14	7.91	0.88	0.44	0.00	0.00	0.00	0.00
tenocyte, donor1	11763-123H8	207.71	91.12	2.79	5.93	8.03	5.93	0.35	4.89
tenocyte, donor2	11765-123I1	109.87	44.64	0.76	3.05	2.29	3.05	0.38	0.00
tenocyte, donor3	11768-123I4	123.06	56.71	0.74	4.45	2.97	2.59	1.11	2.22
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	119.14	33.31	0.51	0.51	0.68	1.02	0.68	0.51
teratocarcinoma cell line:NCR-G1	10798-110I6	191.61	79.69	0.77	0.77	0.92	1.54	0.77	0.62
teratocarcinoma cell line:PA-1	10807-111A6	28.67	8.83	0.15	0.31	0.00	0.15	0.00	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	68.68	27.17	0.25	0.51	0.38	0.13	0.13	0.13
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	132.36	27.98	1.13	1.13	0.38	0.76	0.38	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	107.64	39.81	1.64	0.65	0.55	0.22	0.22	0.33
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	111.06	19.22	1.30	2.93	0.65	1.30	1.63	1.63
testis, adult, pool1	10026-101D8	83.32	24.70	0.21	0.11	0.11	0.00	0.00	0.11
testis, adult, pool2	10096-102C6	101.49	37.89	3.16	3.61	1.35	0.90	0.90	2.71
thalamus - adult, donor10196	10168-103B6	66.24	39.74	1.10	0.00	0.00	1.10	2.21	0.00
thalamus, adult, donor10252	10154-103A1	77.67	53.92	1.09	0.78	1.09	0.47	0.16	0.94
thalamus, adult, donor10258, tech_rep1	10370-105G1	55.43	27.71	0.00	0.00	0.00	0.00	0.00	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	24.04	11.53	0.16	0.16	0.00	0.00	0.00	0.00
thalamus, newborn, donor10223	10366-105F6	25.89	10.93	0.00	0.58	0.00	0.58	0.00	0.00
throat, adult	10209-103G2	119.34	49.93	3.50	1.25	1.75	0.25	0.25	0.25
throat, fetal, donor1	10061-101H7	140.16	68.56	2.44	3.35	1.83	1.22	0.91	1.83
thymic carcinoma cell line:Ty-82	10803-111A2	25.64	11.73	0.20	0.00	0.00	0.00	0.00	0.00
thymus, adult, pool1	10027-101D9	37.18	9.74	0.20	0.20	0.20	0.10	0.10	0.10
thymus, fetal, pool1	10043-101F7	79.59	23.07	0.31	0.10	0.31	0.21	0.10	0.10
thyroid carcinoma cell line:KHM-5M	10776-110G2	115.54	59.03	1.20	0.40	0.40	0.27	0.40	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	63.28	31.85	0.56	0.00	0.84	0.28	0.56	0.28
thyroid, adult, pool1	10028-101E1	180.56	74.65	0.84	0.47	0.56	0.84	0.19	0.37
thyroid, fetal, donor1	10060-101H6	396.81	204.60	3.16	6.06	3.43	3.69	2.64	6.06
tongue epidermis (fungiform papillae), donor1	10288-104F9	150.90	76.99	0.00	3.08	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	57.68	23.72	1.40	0.47	1.16	0.47	0.47	0.00
tongue, fetal, donor1	10059-101H5	62.27	35.07	0.79	0.00	0.79	0.79	0.39	0.00
tonsil, adult, pool1	10047-101G2	142.85	47.08	0.50	0.30	0.10	0.10	0.20	0.10
trachea, adult, pool1	10029-101E2	223.96	69.86	0.49	0.41	0.57	0.57	0.33	0.08
trachea, fetal, donor1	10058-101H4	162.73	103.87	3.46	3.08	1.15	0.38	1.54	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	173.60	85.73	1.77	0.71	1.06	0.35	0.71	2.13
transitional-cell carcinoma cell line:5637	10418-106C4	86.63	25.03	0.61	0.20	0.10	0.00	0.00	0.20
transitional-cell carcinoma cell line:JMSU1	10492-107B6	34.94	8.15	0.47	0.31	0.16	0.16	0.47	0.16
tridermal teratoma cell line:HGRT	10694-109G1	308.21	144.59	0.00	0.00	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	24.80	13.54	0.08	0.08	0.08	0.08	0.08	0.08
umbilical cord, fetal, donor1	10057-101H3	79.29	45.90	2.09	2.09	0.00	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	133.77	33.78	0.68	0.68	0.17	0.34	0.17	0.00
uterus, fetal, donor1	10055-101H1	122.86	69.11	1.54	2.56	3.07	1.54	1.02	1.02
vagina, adult	10204-103F6	87.88	47.82	0.00	0.65	0.65	0.00	0.65	0.65
vein, adult	10191-103E2	64.66	23.67	1.10	0.88	0.88	0.22	0.44	0.44
xeroderma pigentosum b cell line:XPL 17	10563-108A5	17.89	7.74	0.27	0.00	0.53	0.53	0.00	0.00